Peter Gottfried Kremsner
#81,187
Most Influential Person Now
Austrian physician
Peter Gottfried Kremsner's AcademicInfluence.com Rankings
Peter Gottfried Kremsnerphilosophy Degrees
Philosophy
#4709
World Rank
#7325
Historical Rank
Logic
#2113
World Rank
#3030
Historical Rank
Download Badge
Philosophy
Peter Gottfried Kremsner's Degrees
- Doctorate Medicine University of Vienna
- PhD Immunology University of Vienna
Why Is Peter Gottfried Kremsner Influential?
(Suggest an Edit or Addition)According to Wikipedia, Peter Gottfried Kremsner is a specialist in tropical medicine and Full Professor at the University of Tübingen, Germany. Since 1992 he has been leading the Centre de Recherches Médicales de Lambaréné , Gabon, now as president.
Peter Gottfried Kremsner's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Allergy, parasites, and the hygiene hypothesis. (2002) (1562)
- Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10 (2000) (754)
- A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. (2012) (689)
- First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. (2011) (531)
- Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. (2015) (459)
- A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms. (2016) (433)
- Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe. (2016) (389)
- Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren. (2004) (360)
- Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial (2002) (323)
- Sterile protection against human malaria by chemoattenuated PfSPZ vaccine (2017) (296)
- A Research Agenda for Malaria Eradication: Drugs (2011) (287)
- Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine. (2015) (287)
- A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses (2000) (270)
- Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. (1999) (260)
- High recombination rate in natural populations of Plasmodium falciparum. (1999) (259)
- Low Interleukin-12 Activity in Severe Plasmodium falciparum Malaria (2000) (251)
- Comparison of methods for the rapid laboratory assessment of children with malaria. (2001) (237)
- Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial (2015) (233)
- Reduced interleukin-12 and transforming growth factor-beta1 in severe childhood malaria: relationship of cytokine balance with disease severity. (2000) (215)
- Blood Group A Antigen Is a Coreceptor inPlasmodium falciparum Rosetting (2000) (212)
- Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials (2009) (212)
- Fosmidomycin for malaria (2002) (208)
- Severe falciparum malaria in Gabonese children: clinical and laboratory features (2005) (208)
- The role of red blood cell polymorphisms in resistance and susceptibility to malaria. (1999) (198)
- Fosmidomycin, a Novel Chemotherapeutic Agent for Malaria (2003) (193)
- Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria (1998) (190)
- Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials (2020) (184)
- Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like Illness (2014) (177)
- Antimalarial combinations (2004) (176)
- Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambaréné, Gabon. (1998) (174)
- Asymptomatic SARS Coronavirus 2 infection: Invisible yet invincible (2020) (173)
- Plasmodium falciparum activates endogenous Cl− channels of human erythrocytes by membrane oxidation (2002) (170)
- Nitric oxide synthase 2(Lambaréné) (G-954C), increased nitric oxide production, and protection against malaria. (2001) (166)
- Schistosomes Induce Regulatory Features in Human and Mouse CD1dhi B Cells: Inhibition of Allergic Inflammation by IL-10 and Regulatory T Cells (2012) (162)
- Atovaquone and proguanil for Plasmodium falciparum malaria (1996) (160)
- AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial. (2013) (150)
- Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines (2015) (149)
- Malaria epidemiology in the province of Moyen Ogoov, Gabon. (1995) (148)
- A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer☆☆☆ (2014) (147)
- Clindamycin as an Antimalarial Drug: Review of Clinical Trials (2002) (143)
- Placental malaria increases malaria risk in the first 30 months of life. (2008) (140)
- The Prevalence of Parasite Infestation and House Dust Mite Sensitization in Gabonese Schoolchildren (2001) (137)
- High plasma levels of nitrogen oxides are associated with severe disease and correlate with rapid parasitological and clinical cure in Plasmodium falciparum malaria. (1996) (136)
- Selection of a trioxaquine as an antimalarial drug candidate (2008) (135)
- Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumor necrosis factor production. (1995) (134)
- Plasma interleukin-10:Tumor necrosis factor (TNF)-alpha ratio is associated with TNF promoter variants and predicts malarial complications. (2000) (133)
- Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria. (2004) (130)
- Accelerated Clearance of Plasmodium-infected Erythrocytes in Sickle Cell Trait and Annexin-A7 Deficiency (2009) (129)
- Pharmacogenetics of antimalarial drugs: effect on metabolism and transport. (2009) (128)
- Mosquito distribution and entomological inoculation rates in three malaria-endemic areas in Gabon. (2000) (126)
- Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon. (1994) (122)
- Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam (2006) (121)
- Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial. (2011) (121)
- Mannose-binding lectin plasma levels and gene polymorphisms in Plasmodium falciparum malaria. (1998) (121)
- Safety and Enhanced Immunogenicity of a Hepatitis B Core Particle Plasmodium falciparum Malaria Vaccine Formulated in Adjuvant Montanide ISA 720 in a Phase I Trial (2005) (120)
- Elevated Nitric Oxide Production in Children with Malarial Anemia: Hemozoin-Induced Nitric Oxide Synthase Type 2 Transcripts and Nitric Oxide in Blood Mononuclear Cells (2004) (119)
- Antigen-specific proliferation and interferon-gamma and interleukin-5 production are down-regulated during Schistosoma haematobium infection. (1998) (118)
- Malaria chemoprophylaxis with tafenoquine: a randomised study (2000) (118)
- Intermittent Preventive Treatment of Malaria in Pregnancy with Mefloquine in HIV-Negative Women: A Multicentre Randomized Controlled Trial (2014) (117)
- Reduced cord blood immune effector-cell responsiveness mediated by CD4+ cells induced in utero as a consequence of placental Plasmodium falciparum infection. (2006) (117)
- Safety and immunogenicity of GMZ2 - a MSP3-GLURP fusion protein malaria vaccine candidate. (2009) (115)
- Elevated proliferation and interleukin‐4 release from CD4+ cells after chemotherapy in human Schistosoma haematobium infection (1996) (115)
- Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria. (1992) (114)
- Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres (2015) (114)
- Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children (1998) (113)
- Clonal selection drives protective memory B cell responses in controlled human malaria infection (2018) (112)
- Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon. (1997) (111)
- A Head-to-Head Comparison of Four Artemisinin-Based Combinations for Treating Uncomplicated Malaria in African Children: A Randomized Trial (2011) (111)
- High prevalence of asymptomatic Plasmodium falciparum infection in Gabonese adults. (2007) (110)
- Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria (1997) (110)
- Reciprocal Regulation of Th1- and Th2-Cytokine-Producing T Cells during Clearance of Parasitemia in Plasmodium falciparum Malaria (1998) (109)
- Adolescence As Risk Factor for Adverse Pregnancy Outcome in Central Africa – A Cross-Sectional Study (2010) (108)
- Differential Regulation of β-Chemokines in Children with Plasmodium falciparum Malaria (2005) (108)
- Quantitative diagnosis of Schistosoma infections by measurement of circulating antigens in serum and urine. (1994) (107)
- Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon (2008) (107)
- Fosmidomycin-clindamycin for Plasmodium falciparum Infections in African children. (2004) (106)
- Fosmidomycin plus Clindamycin for Treatment of Pediatric Patients Aged 1 to 14 Years with Plasmodium falciparum Malaria (2006) (106)
- Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study. (2001) (105)
- Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial (2004) (105)
- Microscopic and sub-microscopic Plasmodium falciparum infection, but not inflammation caused by infection, is associated with low birth weight. (2006) (102)
- Virulence factors and genotypes of Staphylococcus aureus from infection and carriage in Gabon. (2011) (101)
- Mosaics of gene variations in the Interleukin-10 gene promoter affect interleukin-10 production depending on the stimulation used (2004) (100)
- Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults. (1996) (100)
- Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon. (2008) (99)
- High oxygen radical production is associated with fast parasite clearance in children with Plasmodium falciparum malaria. (1999) (97)
- Tumor necrosis factor in Plasmodium falciparum malaria: high plasma level is associated with fever, but high production capacity is associated with rapid fever clearance. (1997) (97)
- A Duffy binding-like domain is involved in the NKp30-mediated recognition of Plasmodium falciparum-parasitized erythrocytes by natural killer cells. (2007) (95)
- Malaria pigment in leucocytes. (1995) (95)
- Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV (2017) (95)
- Epidemiology of parasitic co‐infections during pregnancy in Lambaréné, Gabon (2010) (93)
- Standardized data collection for multi-center clinical studies of severe malaria in African children: establishing the SMAC network. (2006) (92)
- Detection of the schistosome circulating cathodic antigen by enzyme immunoassay using biotinylated monoclonal antibodies. (1990) (92)
- Plasmodium Induces Swelling-activated ClC-2 Anion Channels in the Host Erythrocyte* (2004) (92)
- Recognition of Variant Rifin Antigens by Human Antibodies Induced during Natural Plasmodium falciparum Infections (2002) (89)
- Plasmodium falciparum: a major role for IgG3 in antibody-dependent monocyte-mediated cellular inhibition of parasite growth in vitro. (2001) (89)
- Fcγ receptor‐mediated phagocytosis of Plasmodium falciparum‐infected erythrocytes in vitro (2002) (89)
- A Randomized Trial Assessing the Safety and Immunogenicity of AS01 and AS02 Adjuvanted RTS,S Malaria Vaccine Candidates in Children in Gabon (2009) (88)
- First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria (2019) (87)
- Association of the ICAM-1Kilifi mutation with protection against severe malaria in Lambaréné, Gabon. (1999) (86)
- Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19 (2021) (86)
- Malarial anaemia in African children associated with high oxygen-radical production (2000) (85)
- Phase 1 Assessment of the Safety and Immunogenicity of an mRNA- Lipid Nanoparticle Vaccine Candidate Against SARS-CoV-2 in Human Volunteers (2020) (85)
- Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity rates (2015) (84)
- The sickle cell trait is associated with enhanced immunoglobulin G antibody responses to Plasmodium falciparum variant surface antigens. (2005) (84)
- Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial. (2007) (83)
- Pentoxifylline prevents murine cerebral malaria. (1991) (81)
- Retrospective analysis of antimicrobial resistance and bacterial spectrum of infection in Gabon, Central Africa (2013) (81)
- Delayed hemolysis after treatment with parenteral artesunate in African children with severe malaria--a double-center prospective study. (2014) (80)
- Emergence of trimethoprim resistance gene dfrG in Staphylococcus aureus causing human infection and colonization in sub-Saharan Africa and its import to Europe. (2014) (80)
- Frequency and virulence properties of diarrheagenic Escherichia coli in children with diarrhea in Gabon. (2003) (80)
- Increased erythropoietin production in children with severe malarial anemia. (1995) (80)
- Widespread expression of MRP8 and MRP14 in human cerebral malaria by microglial cells (1998) (80)
- Import and spread of Panton-Valentine Leukocidin-positive Staphylococcus aureus through nasal carriage and skin infections in travelers returning from the tropics and subtropics. (2012) (79)
- Blood Mononuclear Cell Nitric Oxide Production and Plasma Cytokine Levels in Healthy Gabonese Children with Prior Mild or Severe Malaria (1999) (79)
- Ficolin 2 (FCN2) functional polymorphisms and the risk of rheumatic fever and rheumatic heart disease (2009) (79)
- Effects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46, NKp44 and NKp30) (2005) (78)
- Responses to Toll-like receptor ligands in children living in areas where schistosome infections are endemic. (2004) (78)
- EFFECTS OF INTRADERMAL GAMMA-INTERFERON IN CUTANEOUS LEISHMANIASIS (1989) (77)
- A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children. (2016) (76)
- Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon. (2005) (76)
- Epidemiology of malaria and helminth interaction: a review from 2001 to 2011 (2012) (76)
- Impact of adjuvants on CD4(+) T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial. (2016) (75)
- Serum cytokine profiles associated with clinical presentation in Vietnamese infected with hepatitis B virus. (2003) (75)
- The 3D7var5.2 (varCOMMON) type var gene family is commonly expressed in non-placental Plasmodium falciparum malaria (2003) (74)
- Quinine plus clindamycin improves chemotherapy of severe malaria in children (1995) (74)
- Evidence of decline of malaria in the general hospital of Libreville, Gabon from 2000 to 2008 (2009) (73)
- The impact of malaria on common lipid parameters (2002) (73)
- Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial. (2013) (73)
- Intramuscular Bioavailability and Clinical Efficacy of Artesunate in Gabonese Children with Severe Malaria (2002) (72)
- Uncomplicated malaria. (2005) (72)
- Host genetic factors determining COVID-19 susceptibility and severity (2021) (72)
- Structural characterisation of the distal 5′ flanking region of the human interleukin-10 gene (2001) (71)
- Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients. (2006) (71)
- Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks (2015) (71)
- Antihomotypic affinity maturation improves human B cell responses against a repetitive epitope (2018) (71)
- Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy. (2013) (70)
- Pharmacokinetics of Ferroquine, a Novel 4-Aminoquinoline, in Asymptomatic Carriers of Plasmodium falciparum Infections (2012) (70)
- Short-Course Regimens of Artesunate-Fosmidomycin in Treatment of Uncomplicated Plasmodium falciparum Malaria (2005) (70)
- Population Structure of Staphylococcus aureus from Remote African Babongo Pygmies (2011) (69)
- Functional haplotypes that produce normal ficolin-2 levels protect against clinical leprosy. (2009) (69)
- High burden of extended-spectrum β-lactamase-producing Enterobacteriaceae in Gabon. (2013) (69)
- Haemolysis associated with the treatment of malaria with artemisinin derivatives: a systematic review of current evidence. (2014) (69)
- Antischistosomal activity of artemisinin derivatives in vivo and in patients. (2016) (69)
- The association between mannan-binding lectin gene polymorphism and clinical leprosy: new insight into an old paradigm. (2007) (69)
- Rapid diagnosis of schistosomiasis by antigen detection in urine with a reagent strip (1994) (68)
- Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria (1997) (68)
- A Randomized Controlled Phase Ib Trial of the Malaria Vaccine Candidate GMZ2 in African Children (2011) (67)
- Schistosoma mansoni: adhesion of mannan-binding lectin to surface glycoproteins of cercariae and adult worms. (2000) (67)
- Recognition of Plasmodium falciparum proteins by mannan-binding lectin, a component of the human innate immune system (2002) (67)
- DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection (2017) (67)
- Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial. (2005) (67)
- Evaluation of the safety and immunogenicity of the RTS,S/AS01E malaria candidate vaccine when integrated in the expanded program of immunization. (2010) (67)
- Inverse relationship of plasma prostaglandin E2 and blood mononuclear cell cyclooxygenase-2 with disease severity in children with Plasmodium falciparum malaria. (2001) (67)
- A comparative trial of three regimens for treating uncomplicated falciparum malaria in Acre, Brazil. (1988) (67)
- Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection (2018) (66)
- The malaria vaccine candidate GMZ2 elicits functional antibodies in individuals from malaria endemic and non-endemic areas. (2013) (65)
- Plasmodium vivax malaria in Duffy-negative individuals from Ethiopia. (2013) (65)
- Circulating anodic and cathodic antigen in serum and urine from Schistosoma haematobium-infected Cameroonian children receiving praziquantel: a longitudinal study. (1994) (65)
- History and perspectives of medical research at the Albert Schweitzer Hospital in Lambaréné, Gabon (2007) (65)
- Staphylococcus aureus complex from animals and humans in three remote African regions. (2015) (65)
- Association of a new mannose-binding lectin variant with severe malaria in Gabonese children (2006) (64)
- Epidemiology and population structure of Staphylococcus aureus in various population groups from a rural and semi urban area in Gabon, Central Africa. (2012) (64)
- Incidence, pathogens and resistance patterns of nosocomial infections at a rural hospital in Gabon (2014) (64)
- Impact of Sickle Cell Trait and Naturally Acquired Immunity on Uncomplicated Malaria after Controlled Human Malaria Infection in Adults in Gabon (2017) (64)
- In vitro activity of quinolines against Plasmodium falciparum in Gabon. (2004) (64)
- Assessment of Volume Depletion in Children with Malaria (2004) (64)
- Antibodies to Plasmodium falciparum Rifin Proteins Are Associated with Rapid Parasite Clearance and Asymptomatic Infections (2003) (64)
- Frequency of cytokine-producing T cells in patients of different age groups with Plasmodium falciparum malaria. (1999) (63)
- Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization☆ (2017) (63)
- Malaria in pregnancy before and after the implementation of a national IPTp program in Gabon. (2007) (63)
- Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambaréné, Gabon. (2010) (63)
- Tumor necrosis factor alpha antagonist drugs and leishmaniasis in Europe. (2012) (63)
- Randomized, Controlled, Assessor-Blind Clinical Trial To Assess the Efficacy of Single- versus Repeated-Dose Albendazole To Treat Ascaris lumbricoides, Trichuris trichiura, and Hookworm Infection (2014) (62)
- Hepatitis B virus‐induced hepatocellular carcinoma: functional roles of MICA variants (2013) (62)
- Cellular and humoral responses to influenza in gabonese children living in rural and semi-urban areas. (2007) (62)
- Age-Related Buildup of Humoral Immunity against Epitopes for Rosette Formation and Agglutination in African Areas of Malaria Endemicity (1998) (62)
- Reassessment of the resistance of Plasmodium falciparum to chloroquine in Gabon: implications for the validity of tests in vitro vs. in vivo. (2002) (62)
- Interleukin 10 (IL-10)-producing CD1dhi regulatory B cells from Schistosoma haematobium-infected individuals induce IL-10-positive T cells and suppress effector T-cell cytokines. (2014) (61)
- Preparedness is essential for malaria-endemic regions during the COVID-19 pandemic (2020) (61)
- The Lambaréné Organ Dysfunction Score (LODS) is a simple clinical predictor of fatal malaria in African children. (2009) (61)
- Depressed natural killer cell cytotoxicity against Plasmodium falciparum-infected erythrocytes during first pregnancies. (2004) (60)
- Young adolescent girls are at high risk for adverse pregnancy outcomes in sub-Saharan Africa: an observational multicountry study (2016) (60)
- Cortisol and susceptibility to malaria during pregnancy. (2005) (60)
- Likely Health Outcomes for Untreated Acute Febrile Illness in the Tropics in Decision and Economic Models; A Delphi Survey (2011) (59)
- Efficacy of mefloquine intermittent preventive treatment in pregnancy against Schistosoma haematobium infection in Gabon: a nested randomized controlled assessor-blinded clinical trial. (2013) (59)
- Plasmodium falciparum: molecular background to strain-specific rosette disruption by glycosaminoglycans and sulfated glycoconjugates. (1999) (59)
- Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, Nigeria (2007) (59)
- A model for estimating total parasite load in falciparum malaria patients. (2002) (58)
- New emerging Plasmodium falciparum genotypes in children during the transition phase from asymptomatic parasitemia to malaria. (2002) (58)
- In vitro activity of ferroquine (SAR97193) is independent of chloroquine resistance in Plasmodium falciparum. (2006) (57)
- Randomized Controlled Trial of Fosmidomycin-Clindamycin versus Sulfadoxine-Pyrimethamine in the Treatment of Plasmodium falciparum Malaria (2007) (57)
- Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial (2021) (57)
- Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study. (2018) (56)
- Plasmodium falciparum: in vitro growth inhibition by febrile temperatures (2001) (56)
- Highly divergent Staphylococcus aureus isolates from African non-human primates. (2012) (56)
- Angiogenic proteins in brains of patients who died with cerebral malaria (2003) (55)
- Socio-economic status is inversely related to bed net use in Gabon (2008) (55)
- Reduced antibody responses against Plasmodium falciparum vaccine candidate antigens in the presence of Trichuris trichiura. (2012) (55)
- IFN-γ and IL-10 Mediate Parasite-Specific Immune Responses of Cord Blood Cells Induced by Pregnancy-Associated Plasmodium falciparum Malaria1 (2005) (54)
- Mannose-binding lectin gene polymorphisms and hepatitis B virus infection in Vietnamese patients. (2003) (54)
- Full blood count and haemozoin-containing leukocytes in children with malaria: diagnostic value and association with disease severity (2008) (54)
- Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study. (2015) (54)
- Natural killer (NK) cell-mediated cytolysis of Plasmodium falciparum-infected human red blood cells in vitro. (2003) (54)
- Malaria antigen and cytokine-induced production of reactive nitrogen intermediates by murine macrophages: no relevance to the development of experimental cerebral malaria. (1993) (54)
- Prognostic value of circulating pigmented cells in African children with malaria. (2009) (54)
- Submicroscopic Plasmodium falciparum infections and multiplicity of infection in matched peripheral, placental and umbilical cord blood samples from Gabonese women (2004) (53)
- Matrix metalloproteinases and their tissue inhibitors (TIMPs) in Plasmodium falciparum malaria: serum levels of TIMP-1 are associated with disease severity. (2008) (53)
- Functional Impairment of Human Myeloid Dendritic Cells during Schistosoma haematobium Infection (2010) (53)
- Low-Dose Treatment with Sulfadoxine-Pyrimethamine Combinations Selects for Drug-Resistant Plasmodium falciparum Strains (1999) (52)
- Persistent Nasal Carriage of Staphylococcus aureus Is Associated with Deficient Induction of Human β-Defensin 3 after Sterile Wounding of Healthy Skin In Vivo (2011) (52)
- Pregnancy-associated malaria affects toll-like receptor ligand-induced cytokine responses in cord blood. (2008) (52)
- Phase I randomized dose-ascending placebo-controlled trials of ferroquine - a candidate anti-malarial drug - in adults with asymptomatic Plasmodium falciparum infection (2011) (52)
- The Cost-Effectiveness of Intermittent Preventive Treatment for Malaria in Infants in Sub-Saharan Africa (2010) (52)
- Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria. (2006) (52)
- Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial (2017) (51)
- Artesunate – amodiaquine combination therapy for falciparum malaria in young Gabonese children (2007) (51)
- Plasma levels of artesunate and dihydroartemisinin in children with Plasmodium falciparum malaria in Gabon after administration of 50-milligram artesunate suppositories. (1998) (51)
- Clinical and parasitological characteristics of puerperal malaria. (2005) (51)
- Immune responses induced by repeated treatment do not result in protective immunity to Schistosoma haematobium: interleukin (IL)-5 and IL-10 responses. (2002) (51)
- Neutrophils and monocytes from subjects with the Mediterranean G6PD variant: effect of Plasmodium falciparum hemozoin on G6PD activity, oxidative burst and cytokine production. (1998) (50)
- Differential effects of human serum and cells on the growth of Plasmodium falciparum adapted to serum-free in vitro culture conditions. (1997) (50)
- Transmission of Staphylococcus aureus between mothers and infants in an African setting. (2014) (50)
- Ficolin-2 Levels and FCN2 Haplotypes Influence Hepatitis B Infection Outcome in Vietnamese Patients (2011) (50)
- Variants of Plasmodium falciparum erythrocyte membrane protein 1 expressed by different placental parasites are closely related and adhere to chondroitin sulfate A. (2001) (50)
- Herd immunity and vaccination of children for COVID-19 (2020) (49)
- HLA-DQB1*0501-restricted Th1 type immune responses to Plasmodium falciparum liver stage antigen 1 protect against malaria anemia and reinfections. (2001) (49)
- Hemozoin differentially modulates the production of interleukin 6 and tumor necrosis factor in murine malaria. (1995) (49)
- Mosquito Passage Dramatically Changes var Gene Expression in Controlled Human Plasmodium falciparum Infections (2016) (49)
- Persistence of vaccine-induced antibodies to hepatitis B surface antigen and the need for booster vaccination in adult subjects. (1987) (48)
- CD4+CD25hiFOXP3+ Regulatory T Cells and Cytokine Responses in Human Schistosomiasis before and after Treatment with Praziquantel (2015) (48)
- PCR typing of Plasmodium falciparum in matched peripheral, placental and umbilical cord blood (2002) (48)
- Effects of Plasmodium vinckei hemozoin on the production of oxygen radicals and nitrogen oxides in murine macrophages. (1996) (48)
- Short-Course Artesunate Treatment of Uncomplicated Plasmodium falciparum Malaria in Gabon (2003) (48)
- Hemolysis Is Associated with Low Reticulocyte Production Index and Predicts Blood Transfusion in Severe Malarial Anemia (2010) (48)
- Interferon‐γ induced lethality in the late phase of Plasmodium vinckei malaria despite effective parasite clearance by chloroquine (1992) (48)
- Reduced Peripheral PGE2 Biosynthesis in Plasmodium falciparum Malaria Occurs through Hemozoin-Induced Suppression of Blood Mononuclear Cell Cyclooxygenase-2 Gene Expression via an Interleukin-10-Independent Mechanism (2004) (47)
- Heme oxygenase-1 in lesions of human cerebral malaria (2000) (47)
- Association of vitamin D deficiency with hepatitis B virus - related liver diseases (2016) (47)
- Levels of the schistosome circulating anodic and cathodic antigens in serum of schistosomiasis patients from Brazil. (1991) (47)
- No evidence of Wolbachia endosymbiosis with Loa loa and Mansonella perstans (2003) (46)
- The 3D7var5.2 (var COMMON) type var gene family is commonly expressed in non-placental Plasmodium falciparum malaria. (2003) (46)
- Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa? (2015) (46)
- Short-term economic impact of the Zika virus outbreak. (2016) (46)
- Species and genotype diversity of Plasmodium in malaria patients from Gabon analysed by next generation sequencing (2017) (46)
- Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines. (2002) (45)
- Do paediatric drug formulations of artemisinin combination therapies improve the treatment of children with malaria? A systematic review and meta-analysis. (2010) (45)
- Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled Trial (2016) (45)
- Functional analysis of a promoter variant of the gene encoding the interferon-gamma receptor chain I (2003) (45)
- Induction of Plasmodium falciparum-Specific CD4+ T Cells and Memory B Cells in Gabonese Children Vaccinated with RTS,S/AS01E and RTS,S/AS02D (2011) (45)
- High efficacy of short-term quinine-antibiotic combinations for treating adult malaria patients in an area in which malaria is hyperendemic (1995) (44)
- Parasite antigen-specific interleukin-10 and antibody reponses predict accelerated parasite clearance in Plasmodium falciparum malaria. (1999) (43)
- A thirteen-year analysis of Plasmodium falciparum populations reveals high conservation of the mutant pfcrt haplotype despite the withdrawal of chloroquine from national treatment guidelines in Gabon (2011) (43)
- The Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria Vaccine (2015) (43)
- Ficolin-2 levels and FCN2 genetic polymorphisms as a susceptibility factor in schistosomiasis. (2012) (43)
- Differences in presentation of severe malaria in urban and rural Gabon. (2007) (43)
- Hyperparasitemia and blood exchange transfusion for treatment of children with falciparum malaria. (1998) (42)
- Hormonal contraceptive use and persistent Staphylococcus aureus nasal carriage. (2012) (42)
- Serum protein concentrations in Plasmodium falciparum malaria. (1992) (42)
- A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and Africa (2017) (42)
- Plasmodia express two threonine-peptidase complexes during asexual development. (2006) (42)
- Immune response in patients during and after Plasmodium falciparum infection. (1990) (42)
- Phylogenetic nomenclature and evolution of mannose-binding lectin (MBL2) haplotypes (2010) (42)
- No influence of socioeconomic factors on severe malarial anaemia, hyperparasitaemia or reinfection. (1998) (42)
- Bacterial strains isolated from blood cultures of Nigerian children with cerebral malaria (1993) (42)
- DNA phasing by TA dinucleotide microsatellite length determines in vitro and in vivo expression of the gp91phox subunit of NADPH oxidase and mediates protection against severe malaria. (2004) (41)
- Uncommon asymptomatic Plasmodium falciparum infections in Gabonese children. (2003) (41)
- Increased prevalence of intestinal helminth infection during pregnancy in a Sub-Saharan African community (2007) (41)
- Lesion associated expression of urokinase-type plasminogen activator receptor (uPAR, CD87) in human cerebral malaria (2000) (40)
- Community response to intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in five African settings (2009) (40)
- Genetic Evidence of Functional Ficolin-2 Haplotype as Susceptibility Factor in Cutaneous Leishmaniasis (2012) (40)
- High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese children (2011) (40)
- Delayed haemolysis after artesunate treatment of severe malaria - review of the literature and perspective. (2015) (40)
- Differential Cellular Accumulation of Transforming Growth Factor-β1, -β2, and -β3 in Brains of Patients Who Died with Cerebral Malaria (2000) (40)
- Focal accumulation of cyclooxygenase-1 (COX-1) and COX-2 expressing cells in cerebral malaria (2000) (40)
- Drug sensitivity of Plasmodium falciparum in Gabon. Activity correlations between various antimalarials. (1994) (40)
- Reasons for non-adherence to vaccination at mother and child care clinics (MCCs) in Lambaréné, Gabon. (2009) (40)
- MICROSCOPIC AND SUBMICROSCOPIC PLASMODIUM FALCIPARUM INFECTION , BUT NOT INFLAMMATION CAUSED BY INFECTION , IS ASSOCIATED WITH LOW BIRTH WEIGHT (2006) (39)
- Short report: Piloting paperless data entry for clinical research in Africa. (2005) (39)
- A simplified intravenous artesunate regimen for severe malaria. (2012) (39)
- Low antibody responses to variant surface antigens of Plasmodium falciparum are associated with severe malaria and increased susceptibility to malaria attacks in Gabonese children. (2002) (39)
- Increased specific T cell cytokine responses in patients with active pulmonary tuberculosis from Central Africa. (2005) (39)
- Specific cytokine patterns of pulmonary tuberculosis in Central Africa. (2011) (39)
- Plasmodium falciparum transmission intensity and infection rates in children in Gabon (2001) (39)
- In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays (2009) (39)
- Cellular and humoral responses to tetanus vaccination in Gabonese children. (2008) (38)
- Repurposing Antimalarials to Tackle the COVID-19 Pandemic (2020) (38)
- Urogenital schistosomiasis during pregnancy is associated with low birth weight delivery: analysis of a prospective cohort of pregnant women and their offspring in Gabon. (2017) (38)
- Influence of carriage of hemoglobin AS and the Fc gamma receptor IIa-R131 allele on levels of immunoglobulin G2 antibodies to Plasmodium falciparum merozoite antigens in Gabonese children. (2005) (38)
- Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 (2021) (38)
- Suppression of prostaglandin E2 by malaria parasite products and antipyretics promotes overproduction of tumor necrosis factor-alpha: association with the pathogenesis of childhood malarial anemia. (2006) (38)
- Day-to-day variation of egg output and schistosome circulating antigens in urine of Schistosoma haematobium-infected school children from Gabon and follow-up after chemotherapy. (1997) (38)
- A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria (2017) (38)
- Anti-schistosome IgG4 and IgE at 2 years after chemotherapy: infected versus uninfected individuals. (1997) (37)
- Pharmacokinetics of two paediatric artesunate mefloquine drug formulations in the treatment of uncomplicated falciparum malaria in Gabon. (2007) (37)
- Prospective evaluation of artemether-lumefantrine for the treatment of non-falciparum and mixed-species malaria in Gabon (2012) (37)
- Atovaquone and proguanil hydrochloride for prophylaxis of malaria. (1999) (37)
- Effectiveness of quinine monotherapy for the treatment of Plasmodium falciparum infection in pregnant women in Lambaréné, Gabon. (2005) (37)
- A Novel Multivalent OspA Vaccine against Lyme Borreliosis Is Safe and Immunogenic in an Adult Population Previously Infected with Borrelia burgdorferi Sensu Lato (2014) (37)
- High Prevalence of Human Antibodies to Recombinant Duffy Binding-Like α Domains of the Plasmodium falciparum-Infected Erythrocyte Membrane Protein 1 in Semi-Immune Adults Compared to That in Nonimmune Children (2001) (37)
- Prevention of traveller ' s diarrhea : Comparison of different non-antibiotic preparations (1999) (37)
- Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa (2019) (37)
- Controlled human malaria infection of healthy lifelong malaria-exposed adults to assess safety, immunogenicity and efficacy of the asexual blood stage malaria vaccine candidate GMZ2. (2019) (36)
- Enhanced production of reactive nitrogen intermediates in human and murine malaria. (1995) (36)
- Population Pharmacokinetics of Intravenous Artesunate: A Pooled Analysis of Individual Data From Patients With Severe Malaria (2014) (36)
- Comparison of PCR-based detection of Plasmodium falciparum infections based on single and multicopy genes (2007) (36)
- Clindamycin in malaria treatment. (1990) (36)
- Promoter variants of the human mannose-binding lectin gene show different binding. (2000) (36)
- The blood transcriptome of childhood malaria (2019) (36)
- TNFalpha-308A associated with shorter intervals of Plasmodium falciparum reinfections. (2002) (36)
- Curing of chloroquine-resistant malaria with clindamycin. (1993) (35)
- Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria (2008) (35)
- Characterisation of a tryptophan-rich Plasmodium falciparum antigen associated with merozoites. (2004) (35)
- Atovaquone plus proguanil is an effective treatment for Plasmodium ovale and P. malariae malaria. (1996) (35)
- Host cell factor CD59 restricts complement lysis of Plasmodium falciparum‐infected erythrocytes (1997) (35)
- Clinical, Environmental, and Serologic Surveillance Studies of Melioidosis in Gabon, 2012–2013 (2015) (34)
- Clinical implications of Plasmodium resistance to atovaquone/proguanil: a systematic review and meta-analysis (2017) (34)
- Human IgE, IgG subclass, and IgM responses to worm and egg antigens in schistosomiasis haematobium: a 12-month study of reinfection in Cameroonian children. (1998) (34)
- The risk to import ESBL-producing Enterobacteriaceae and Staphylococcus aureus through chicken meat trade in Gabon (2014) (34)
- Schistosoma haematobium effects on Plasmodium falciparum infection modified by soil-transmitted helminths in school-age children living in rural areas of Gabon (2018) (34)
- Cytokines in malaria, pathology and protection (1994) (34)
- Extensive Immunoglobulin Binding of Plasmodium falciparum-Infected Erythrocytes in a Group of Children with Moderate Anemia (1998) (34)
- Controlled human malaria infection with Plasmodium falciparum demonstrates impact of naturally acquired immunity on virulence gene expression (2019) (34)
- The multiplicity of Plasmodium falciparum infections is associated with acquired immunity to asexual blood stage antigens. (2009) (34)
- Therapy of uncomplicated falciparum malaria in Europe: MALTHER – a prospective observational multicentre study (2012) (34)
- Arteflene compared with mefloquine for treating Plasmodium falciparum malaria in children. (1996) (33)
- Cord Blood Dendritic Cell Subsets in African Newborns Exposed to Plasmodium falciparum In Utero (2006) (33)
- Tumour necrosis factor-α and macrophages in Plasmodium berghei-induced cerebral malaria (1993) (33)
- Quantitative determination of circulating anodic and cathodic antigens in serum and urine of individuals infected with Schistosoma intercalatum. (1993) (33)
- Staphylococcus aureus throat carriage is associated with ABO-/secretor status. (2012) (33)
- The effect of immunization schedule with the malaria vaccine candidate RTS,S/AS01E on protective efficacy and anti-circumsporozoite protein antibody avidity in African infants (2015) (33)
- Fosmidomycin as an antimalarial drug: a meta-analysis of clinical trials. (2015) (33)
- A common polymorphism in the mechanosensitive ion channel PIEZO1 is associated with protection from severe malaria in humans (2020) (33)
- Malaria and asymptomatic parasitaemia in Gabonese infants under the age of 3 months. (2005) (33)
- Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection. (2006) (33)
- Antibody responses to Plasmodium falciparum merozoite surface protein-1 and efficacy of amodiaquine in Gabonese children with P. falciparum malaria. (2003) (32)
- Novel and functional regulatory SNPs in the promoter region of FOXP3 gene in a Gabonese population (2011) (32)
- Transport processes in Plasmodium falciparum-infected erythrocytes: potential as new drug targets. (2002) (32)
- Follow-up of the susceptibility of Plasmodium falciparum to antimalarials in Gabon. (1998) (32)
- Inadequate Efficacy of a New Formulation of Fosmidomycin-Clindamycin Combination in Mozambican Children Less than Three Years Old with Uncomplicated Plasmodium falciparum Malaria (2012) (32)
- Declining chloroquine resistance of Plasmodium falciparum in Lambaréné, Gabon from 1992 to 1998. (2001) (32)
- Antibodies to rifin: a component of naturally acquired responses to Plasmodium falciparum variant surface antigens on infected erythrocytes. (2004) (31)
- High Prevalence and Significance of Hepatitis D Virus Infection among Treatment-Naïve HBsAg-Positive Patients in Northern Vietnam (2013) (31)
- Endoglin in African children with Plasmodium falciparum malaria: a novel player in severe malaria pathogenesis? (2009) (31)
- Efficacy and Safety of Fosmidomycin–Piperaquine as Nonartemisinin-Based Combination Therapy for Uncomplicated Falciparum Malaria: A Single-Arm, Age De-escalation Proof-of-Concept Study in Gabon (2017) (31)
- Plasma glutamine and glutamate concentrations in Gabonese children with Plasmodium falciparum infection. (2002) (30)
- Demography, maternal health and the epidemiology of malaria and other major infectious diseases in the rural department Tsamba-Magotsi, Ngounie Province, in central African Gabon (2017) (30)
- Differential var gene expression in children with malaria and antidromic effects on host gene expression. (2010) (30)
- Persistent Epstein-Barr viral reactivation in young African children with a history of severe Plasmodium falciparum malaria. (2006) (30)
- Effectiveness of rifaximin in prevention of diarrhoea in individuals travelling to south and southeast Asia: a randomised, double-blind, placebo-controlled, phase 3 trial. (2013) (30)
- Macrophages/microglial cells in patients with cerebral malaria. (2002) (30)
- Neonatal and Maternal Immunological Responses to Conserved Epitopes within the DBL-γ3 Chondroitin Sulfate A-Binding Domain of Plasmodium falciparum Erythrocyte Membrane Protein 1 (2005) (30)
- Alterations of blood coagulation in controlled human malaria infection (2016) (30)
- In vitro drug sensitivity of Plasmodium falciparum in Acre, Brazil. (1989) (29)
- Delayed parasite elimination in human infections treated with clindamycin parallels 'delayed death' of Plasmodium falciparum in vitro. (2007) (29)
- Analysis of IgG with specificity for variant surface antigens expressed by placental Plasmodium falciparum isolates (2004) (29)
- Prevalence and causative fungal species of tinea capitis among schoolchildren in Gabon (2011) (29)
- Ficolin-2 levels and genetic polymorphisms of FCN2 in malaria. (2011) (29)
- HLA-DP control of human Schistosoma haematobium infection. (1998) (29)
- Sulfadoxine/pyrimethamine or chloroquine/clindamycin treatment of Gabonese school children infected with chloroquine resistant malaria. (1995) (29)
- Case report: Successful treatment of cutaneous leishmaniasis caused by Leishmania aethiopica with liposomal amphothericin B in an immunocompromised traveler returning from Eritrea. (2011) (29)
- Hepatitis E Virus Superinfection and Clinical Progression in Hepatitis B Patients. (2015) (28)
- Efficacy and safety of a new pediatric artesunate-mefloquine drug formulation for the treatment of uncomplicated falciparum malaria in Gabon (2010) (28)
- Functional analysis of a promoter variant of the gene encoding the interferon-gamma receptor chain I (2003) (28)
- The effect of anti‐IL‐10 on proliferation and cytokine production in human schistosomiasis: fresh versus cryopreserved cells (1998) (28)
- No variation in the prevalence of point mutations in the Pfcrt and Pfmdr1 genes in isolates from Gabonese patients with uncomplicated or severe Plasmodium falciparum malaria (2006) (28)
- Mortality Patterns and Site Heterogeneity of Severe Malaria in African Children (2013) (28)
- Association of two variants of the interferon-alpha receptor-1 gene with the presentation of hepatitis B virus infection. (2008) (28)
- Pfmdr1 Alleles and Response to Ultralow-Dose Mefloquine Treatment in Gabonese Patients (2002) (27)
- Atovaquone and proguanil versus amodiaquine for the treatment of Plasmodium falciparum malaria in African infants and young children. (2003) (27)
- Higher production of peripheral blood macrophage migration inhibitory factor in healthy children with a history of mild malaria relative to children with a history of severe malaria. (2007) (27)
- Comparison of Immunological Status of African and European Cord Blood Mononuclear Cells (2008) (27)
- Clinical and Immunologic Follow-up Study of Patients with Neurocysticercosis After Treatment with Praziquantel (1995) (27)
- The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data. (2015) (27)
- HLA class II factors associated with Plasmodium falciparum merozoite surface antigen allele families. (1999) (27)
- MBL2 Variations and Malaria Susceptibility in Indian Populations (2013) (27)
- Prevalence and risk factor assessment of Tropheryma whipplei in a rural community in Gabon: a community-based cross-sectional study. (2014) (27)
- Population genetic analysis of the Plasmodium falciparum erythrocyte binding antigen-175 (eba-175) gene. (2001) (27)
- Plasmodium knowlesi and HIV co-infection in a German traveller to Thailand (2013) (26)
- Immunological alterations in uncomplicated Plasmodium falciparum malaria. Relationship between parasitaemia and indicators of macrophage activation. (1989) (26)
- Assessment of the effect of Schistosoma haematobium co infection on malaria parasites and immune responses in rural populations in Gabon: study protocol (2014) (26)
- Multicentre dose range study of a yeast-derived hepatitis B vaccine. (1987) (26)
- Impact of adjuvants on CD 4 + T cell and B cell responses to a protein antigen vaccine : Results from a phase II , randomized , multicenter trial (2016) (26)
- Co-detection of Panton-Valentine leukocidin encoding genes and cotrimoxazole resistance in Staphylococcus aureus in Gabon: implications for HIV-patients’ care (2015) (26)
- Prospective Clinical and Molecular Evaluation of Potential Plasmodium ovale curtisi and wallikeri Relapses in a High-transmission Setting (2019) (26)
- In Vitro Activity and Interaction of Clindamycin Combined with Dihydroartemisinin against Plasmodium falciparum (2003) (26)
- Therapeutic and prophylactic effect of intermittent preventive anti-malarial treatment in infants (IPTi) from Ghana and Gabon (2008) (25)
- Common surface-antigen var genes of limited diversity expressed by Plasmodium falciparum placental isolates separated by time and space. (2003) (25)
- Streptococcus agalactiae Serotype Distribution and Antimicrobial Susceptibility in Pregnant Women in Gabon, Central Africa (2015) (25)
- Chronic schistosomiasis: dendritic cells generated from patients can overcome antigen-specific T cell hyporesponsiveness. (2000) (25)
- A trivial role of STAT4 variant in chronic hepatitis B induced hepatocellular carcinoma. (2013) (25)
- Effect of antipyretic drugs in children with malaria. (2001) (25)
- Antibody responses to Plasmodium falciparum: evolution according to the severity of a prior clinical episode and association with subsequent reinfection. (2000) (25)
- Plasmodium falciparum: in vitro chloroquine susceptibility and allele-specific PCR detection of Pfmdr1Asn86Tyr polymorphism in Lambarene, Gabon (1998) (25)
- Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial (2021) (25)
- Evidence for the efficacy of artesunate in asymptomatic Plasmodium malariae infections. (2002) (25)
- Nitric oxide and cerebral malaria (1992) (25)
- Immunoglobulin G Isotype Responses to Erythrocyte Surface-Expressed Variant Antigens of Plasmodium falciparum Predict Protection from Malaria in African Children (2005) (25)
- Effect of Antihelminthic Treatment on Vaccine Immunogenicity to a Seasonal Influenza Vaccine in Primary School Children in Gabon: A Randomized Placebo-Controlled Trial (2015) (24)
- Malarial parasites vs. antimalarials: never-ending rumble in the jungle. (2006) (24)
- In Vitro Activity of Mirincamycin (U24729A) against Plasmodium falciparum Isolates from Gabon (2009) (24)
- Malaria chemotherapy trial at a minimal effective dose of mefloquine/sulfadoxine/pyrimethamine compared with equivalent doses of sulfadoxine/pyrimethamine or mefloquine alone. (1998) (24)
- Detectable Vesicular Stomatitis Virus (VSV)–Specific Humoral and Cellular Immune Responses Following VSV–Ebola Virus Vaccination in Humans (2018) (24)
- Staphylococcal disease in Africa: another neglected 'tropical' disease. (2013) (24)
- Var Gene promoter activation in clonal Plasmodium falciparum isolates follows a hierarchy and suggests a conserved switching program that is independent of genetic background. (2011) (24)
- Community-Associated Staphylococcus aureus from Sub-Saharan Africa and Germany: A Cross-Sectional Geographic Correlation Study (2017) (24)
- Variations in the serum concentrations of soluble Fas and soluble Fas ligand in Vietnamese patients infected with hepatitis B virus (2004) (24)
- Mannose-Binding Lectin and Susceptibility to Schistosomiasis (2013) (24)
- Identification of a natural intergenotypic recombinant hepatitis delta virus genotype 1 and 2 in Vietnamese HBsAg‐positive patients (2015) (24)
- Molecular markers of anti-malarial drug resistance in Central, West and East African children with severe malaria (2017) (23)
- Alterations in Peripheral Blood B Cell Subsets and Dynamics of B Cell Responses during Human Schistosomiasis (2013) (23)
- Malaria in pregnancy in rural Gabon: a cross-sectional survey on the impact of seasonality in high-risk groups (2013) (23)
- Prevalence and level of antibodies to the circumsporozoite proteins of human malaria parasites, including a variant of Plasmodium vivax, in the population of two epidemiologically distinct areas in the state of Acre, Brazil. (1992) (23)
- The frontline of controlled human malaria infections: A report from the controlled human infection models Workshop in Leiden University Medical Centre 5 May 2016. (2017) (23)
- Pentoxifylline as an adjunct therapy in children with cerebral malaria (2010) (23)
- Soluble CD8 antigen in Plasmodium falciparum malaria. (1989) (23)
- Antimalarial Activity of a Synthetic Endoperoxide (RBx-11160/OZ277) against Plasmodium falciparum Isolates from Gabon (2006) (23)
- Immunoglobulin G Isotype Responses to Variant Surface Antigens of Plasmodium falciparum in Healthy Gabonese Adults and Children during and after Successive Malaria Attacks (2004) (23)
- Production of interleukin-6 by human and murine mononuclear leukocytes stimulated with Plasmodium antigens is enhanced by pentoxifylline, and tumor necrosis factor secretion is reduced (1993) (23)
- Interleukin-21 is associated with IgG1 and IgG3 antibodies to erythrocyte-binding antigen-175 peptide 4 of Plasmodium falciparum in Gabonese children with acute falciparum malaria. (2008) (23)
- Commonly recognised Plasmodium falciparum parasites cause cerebral malaria (2003) (23)
- Association of in utero sensitization to Schistosoma haematobium with enhanced cord blood IgE and increased frequencies of CD5- B cells in African newborns. (2012) (23)
- Whole-Genome Sequencing to Evaluate the Resistance Landscape Following Antimalarial Treatment Failure With Fosmidomycin-Clindamycin. (2016) (22)
- Properties of the Plasmodium falciparum homologue of a protective vaccine candidate of Plasmodium yoelii. (2001) (22)
- Co-infection of human parvovirus B19 with Plasmodium falciparum contributes to malaria disease severity in Gabonese patients (2013) (22)
- Polymorphisms in the parasite genes for pfcrt and pfmdr-1 as molecular markers for chloroquine resistance in Plasmodium falciparum in Lambaréné, Gabon (2002) (22)
- In vitro activity of artemisone compared with artesunate against Plasmodium falciparum. (2006) (22)
- Atopy and malaria. (2001) (21)
- Tuberculosis Treatment Outcome and Drug Resistance in Lambaréné, Gabon: A Prospective Cohort Study. (2016) (21)
- Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study (2016) (21)
- Recombinase Polymerase Amplification and Lateral Flow Assay for Ultrasensitive Detection of Low-Density Plasmodium falciparum Infection from Controlled Human Malaria Infection Studies and Naturally Acquired Infections (2020) (21)
- Clindamycin treatment of falciparum malaria in Brazil. (1989) (21)
- Circulating levels of the interleukin (IL)-4 receptor and of IL-18 in patients with Plasmodium falciparum malaria. (2005) (21)
- Codiversification of gut microbiota with humans (2021) (21)
- Cytokine and chemokine profile of the innate and adaptive immune response of schistosoma haematobium and plasmodium falciparum single and co-infected school-aged children from an endemic area of Lambaréné, Gabon (2015) (20)
- Combined promoter haplotypes of the IL10R genes are associated with protection against severe malaria in Gabonese children (2012) (20)
- Cytokine profiles in peripheral, placental and cord blood in pregnant women from an area endemic for Plasmodium falciparum. (2004) (20)
- NTCP S267F variant associates with decreased susceptibility to HBV and HDV infection and decelerated progression of related liver diseases. (2019) (20)
- Correlating efficacy and immunogenicity in malaria vaccine trials. (2018) (20)
- Change in Plasmodium falciparum genotype during successive malaria episodes in Gabonese children (2001) (20)
- Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countries (2017) (20)
- Haematological and biochemical reference intervals for infants and children in Gabon (2011) (20)
- Hepatitis E virus genome detection in commercial pork livers and pork meat products in Germany (2020) (20)
- Differing activation status and immune effector molecule expression profiles of neonatal and maternal lymphocytes in an African population (2006) (20)
- Pyrimethamine/sulfadoxine for treating uncomplicated Plasmodium falciparum malaria in young children in Gabon. (1997) (20)
- Enhanced Pro-Inflammatory Cytokine Responses following Toll-Like-Receptor Ligation in Schistosoma haematobium-Infected Schoolchildren from Rural Gabon (2011) (20)
- Effects of Plasmodium falciparum Parasite Population Size and Patient Age on Early and Late Parasitological Outcomes of Antimalarial Treatment in Children (2008) (20)
- Selective damage of hippocampal neurons in murine cerebral malaria prevented by pentoxifylline (1993) (19)
- Lack of induction of IgE and IgG antibodies to yeast in humans immunized with recombinant hepatitis B vaccines. (1988) (19)
- The dynamics of a soluble egg antigen of Schistosoma haematobium in relation to egg counts, circulating anodic and cathodic antigens and pathology markers before and after chemotherapy. (1998) (19)
- Human Plasmodium vivax diversity, population structure and evolutionary origin (2020) (19)
- 5-day nonobserved artesunate monotherapy for treating uncomplicated Falciparum malaria in young Gabonese children. (2005) (19)
- Increased frequency of Th2-type cytokine-producing T cells in microfilaremic loiasis. (1999) (19)
- Upregulation of reactive oxygen and nitrogen intermediates in Plasmodium berghei infected mice after rescue therapy with chloroquine or artemether. (1996) (19)
- Assessment of LED fluorescence microscopy for the diagnosis of Plasmodium falciparum infections in Gabon (2011) (19)
- High Hepatitis E virus (HEV) Positivity Among Domestic Pigs and Risk of HEV Infection of Individuals Occupationally Exposed to Pigs and Pork Meat in Hanoi, Vietnam (2019) (19)
- Life-span of in vitro differentiated Plasmodium falciparum gametocytes (2017) (19)
- Reliable and rapid characterization of functional FCN2 gene variants reveals diverse geographical patterns (2012) (19)
- Rare, highly pyrimethamine-resistant alleles of the Plasmodium falciparum dihydrofolate reductase gene from 5 African sites. (2004) (19)
- NCF1 gene and pseudogene pattern: association with parasitic infection and autoimmunity (2008) (19)
- Activation Status of Cord Blood γδ T Cells Reflects In Utero Exposure to Plasmodium falciparum Antigen (2005) (18)
- IRON CHELATORS: CORRELATION BETWEEN EFFECTS ON PLASMODIUM SPP. AND IMMUNE FUNCTIONS (2006) (18)
- Longitudinal Monitoring of Lactate in Hospitalized and Ambulatory COVID-19 Patients (2021) (18)
- Atovaquone and proguanil hydrochloride for treatment of malaria. (1999) (18)
- Haplotype specific-sequencing reveals MBL2 association with asymptomatic Plasmodium falciparum infection (2009) (18)
- Assessment of fever in African children: implication for malaria trials. (2010) (18)
- Interferon-gamma enhances the effect of antimalarial chemotherapy in murine Plasmodium vinckei malaria. (1991) (18)
- Lactic acidosis in Gabonese children with severe malaria is unrelated to dehydration. (2006) (18)
- Emerging drugs for malaria (2012) (18)
- Dengue and chikungunya seroprevalence in Gabonese infants prior to major outbreaks in 2007 and 2010: A sero-epidemiological study. (2016) (18)
- Lectin Complement Protein Collectin 11 (CL-K1) and Susceptibility to Urinary Schistosomiasis (2015) (18)
- Community-acquired pneumonia in children in Lambarene, Gabon. (2008) (17)
- Inhibition of Plasmodium vinckei-malaria in mice by recombinant murine interferon-gamma. (1988) (17)
- Economic Evaluation of an Alternative Drug to Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy (2015) (17)
- SOCS3 genetic variants and promoter hypermethylation in patients with chronic hepatitis B (2017) (17)
- Ivermectin Impairs the Development of Sexual and Asexual Stages of Plasmodium falciparum In Vitro (2019) (17)
- Association of CISH -292A/T genetic variant with hepatitis B virus infection (2012) (17)
- HLA DRB1-DQA1-DQB1 haplotype diversity in two African populations. (1997) (17)
- Differences in drug response of Plasmodium falciparum within an area of the Amazon region. (1989) (17)
- Nitric oxide generation in children with malaria and the NOS2G-954C promoter polymorphism. (2010) (17)
- Is flow cytometry better in counting malaria pigment-containing leukocytes compared to microscopy? (2009) (17)
- COVID-19 and syndemic challenges in ‘Battling the Big Three’: HIV, TB and malaria⋆ (2021) (17)
- Age-dependency of Plasmodium falciparum-specific and non-specific T cell cytokine responses in individuals from a malaria-endemic area. (2005) (17)
- Controlled human infections: A report from the controlled human infection models workshop, Leiden University Medical Centre 4-6 May 2016. (2017) (17)
- Recombinant Duffy binding-like-α domains of Plasmodium falciparum erythrocyte membrane protein 1 elicit antibodies in rats that recognise conserved epitopes (2003) (16)
- Complement activation in primiparous women from a malaria endemic area is associated with reduced birthweight. (2013) (16)
- Sporozoite Route of Infection Influences In Vitro var Gene Transcription of Plasmodium falciparum Parasites From Controlled Human Infections. (2016) (16)
- Transmission of Cryptosporidium Species Among Human and Animal Local Contact Networks in Sub-Saharan Africa: A Multicountry Study (2020) (16)
- Severe malarial anemia associated with increased soluble Fas ligand (sFasL) concentrations in Gabonese children. (2003) (16)
- Tumour necrosis factor-alpha and macrophages in Plasmodium berghei-induced cerebral malaria. (1993) (16)
- A three base pair gene variation within the distal 5'-flanking region of the interleukin-10 (IL-10) gene is related to the in vitro IL-10 production capacity of lipopolysaccharide-stimulated peripheral blood mononuclear cells. (2004) (16)
- Accumulation of endostatin/collagenXVIII in brains of patients who died with cerebral malaria (2002) (16)
- Increase in annexin V-positive B cells expressing LILRB1/ILT2/CD85j in malaria. (2006) (16)
- Overexpression of endothelium-derived nitric oxide synthase isoform 3 in the vasculature of human pancreatic tumor biopsies (1998) (16)
- New method to quantify erythrophagocytosis by autologous monocytes (2007) (16)
- Comparison of micronized halofantrine with chloroquine-antibiotic combinations for treating Plasmodium falciparum malaria in adults from Gabon. (1994) (16)
- Plasmodium falciparum-Infected Erythrocytes and IL-12/IL-18 Induce Diverse Transcriptomes in Human NK Cells: IFN-α/β Pathway versus TREM Signaling (2011) (16)
- A promoter polymorphism in the interferon alpha-2 gene is associated with the clinical presentation of hepatitis B. (2006) (16)
- Genomic surveillance of SARS-CoV-2 in the Republic of Congo (2021) (16)
- African-European differences in the capacity of T-cell cytokine production. (2001) (16)
- Differential cellular accumulation of transforming growth factor-beta1, -beta2, and -beta3 in brains of patients who died with cerebral malaria. (2000) (16)
- FOXO3A regulatory polymorphism and susceptibility to severe malaria in Gabonese children (2015) (16)
- Severe malaria in children leads to a significant impairment of transitory otoacoustic emissions - a prospective multicenter cohort study (2015) (16)
- Shared breastfeeding in central Africa (2004) (15)
- Molecular characterization of Shigella spp. from patients in Gabon 2011-2013. (2015) (15)
- Progress with PfSPZ Vaccine, a radiation attenuated Plasmodium falciparum sporozoite vaccine (2014) (15)
- Upregulation of ICAM-I by Plasmodium falciparum: in vitro and in vivo studies. (1994) (15)
- LC-MS/MS method for the simultaneous quantification of artesunate and its metabolites dihydroartemisinin and dihydroartemisinin glucuronide in human plasma (2014) (15)
- Systems analysis and controlled malaria infection in Europeans and Africans elucidate naturally acquired immunity (2021) (15)
- Schistosoma haematobium infection is associated with lower serum cholesterol levels and improved lipid profile in overweight/obese individuals (2020) (15)
- Classification of Rhinoentomophthoromycosis into Atypical, Early, Intermediate, and Late Disease: A Proposal (2015) (15)
- Plasmodium falciparum-specific interleukin-2 and tumor necrosis factor-alpha expressing-T cells are associated with resistance to reinfection and severe malaria in healthy African children. (2004) (14)
- Use of Capillary Blood Samples Leads to Higher Parasitemia Estimates and Higher Diagnostic Sensitivity of Microscopic and Molecular Diagnostics of Malaria Than Venous Blood Samples (2018) (14)
- Monitoring of efficacy, tolerability and safety of artemether–lumefantrine and artesunate–amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial (2019) (14)
- Glucose-6-phosphate dehydrogenase deficiency and reduced haemoglobin levels in African children with severe malaria (2016) (14)
- No rebound of morbidity following intermittent preventive sulfadoxine-pyrimethamine treatment of malaria in infants in Gabon. (2009) (14)
- Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults: a randomised, controlled, double-blind, phase 1 dose-escalation trial. (2020) (14)
- Streptococcus pneumoniae colonization in remote African Pygmies. (2013) (14)
- Immunologic activity of schistosomal and bacterial TLR2 ligands in Gabonese children (2007) (14)
- Simplified multi-organ dysfunction score predicts disability in African children with Plasmodium falciparum malaria. (2006) (14)
- Ivermectin for causal malaria prophylaxis: a randomised controlled human infection trial (2019) (14)
- Normal riboflavin status in malaria patients in Gabon. (2003) (14)
- Transcriptome profiling reveals functional variation in Plasmodium falciparum parasites from controlled human malaria infection studies (2019) (14)
- The circadian rhythm of body temperature is preserved during malarial fever. (2000) (14)
- Drug susceptibility of Plasmodium falciparum in the western Amazon region, State of Acre, Brazil. (1991) (13)
- Application of anti-TNF to Plasmodium vinckei-infected mice is followed by an increase of parasitaemia. (1989) (13)
- Carriage of encapsulated bacteria in Gabonese children with sickle cell anaemia. (2013) (13)
- In vitro activity of tigecycline in Plasmodium falciparum culture-adapted strains and clinical isolates from Gabon. (2010) (13)
- ABO blood group and the risk of placental malaria in sub-Saharan Africa (2011) (13)
- SARS-CoV-2 Antibodies Are Persisting in Saliva for More Than 15 Months After Infection and Become Strongly Boosted After Vaccination (2021) (13)
- Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria. (1988) (13)
- Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-Monitored Challenge Model of COVID-19 in Healthy Volunteers (2020) (13)
- Activation status of cord blood gamma delta T cells reflects in utero exposure to Plasmodium falciparum antigen. (2005) (13)
- Hepatitis E Virus Superinfection and Clinical Progression in Hepatitis B Patients (2015) (13)
- Interference by antimalarial drugs with the in-vitro production of reactive nitrogen intermediates by murine macrophages. (1993) (13)
- Phase 2a, Open-Label, 4-Escalating-Dose, Randomized Multicenter Study Evaluating the Safety and Activity of Ferroquine (SSR97193) Plus Artesunate, versus Amodiaquine Plus Artesunate, in African Adult Men with Uncomplicated Plasmodium falciparum Malaria. (2017) (13)
- Efficacy and Safety of the CVnCoV SARS-CoV-2 mRNA Vaccine Candidate: Results from Herald, a Phase 2b/3, Randomised, Observer-Blinded, Placebo-Controlled Clinical Trial in Ten Countries in Europe and Latin America (2021) (13)
- Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria – a proposed model-derived age-based regimen for sub-Saharan Africa (2018) (13)
- Monitoring the threatened utility of malaria rapid diagnostic tests by novel high-throughput detection of Plasmodium falciparum hrp2 and hrp3 deletions: A cross-sectional, diagnostic accuracy study (2019) (12)
- Reactogenicity and immunogenicity of different lots of a yeast-derived hepatitis B vaccine. (1987) (12)
- Combination chemotherapy for Plasmodium falciparum malaria. (1997) (12)
- Frequency of cytokine-producing CD4-CD8- peripheral blood mononuclear cells in patients with Plasmodium falciparum malaria. (1999) (12)
- Prevention of murine cerebral malaria by a stable prostacyclin analog (1991) (12)
- BOOSTING PROPERTIES OF RECOMBINANT DNA HEPATITIS B VACCINE (1986) (12)
- No change in parasite genotype during single episodes of Plasmodium falciparum malaria in Gabonese children (2004) (12)
- Interferon-stimulated gene 15 in hepatitis B-related liver diseases (2016) (12)
- Reciprocal Regulation of Th 1-and Th 2-Cytokine-Producing T Cells during Clearance of Parasitemia in Plasmodium falciparum Malaria (1998) (12)
- Assessment of a simplified method for counting leukocytic malaria pigment. (2005) (11)
- Semiautomated and simultaneous analysis of the interleukin-10 gene microsatellites IL-10G and IL-10R by fluorescence-based polymerase chain reaction reveals significant differences in allele distributions between Caucasians (Germany) and Africans (Gabon). (2001) (11)
- Schistosoma japonicum infection and rectal carcinoid tumour: underreported coincidence or neglected association? (2010) (11)
- Iron chelators as drugs against malaria pose a potential risk (2003) (11)
- Development of sustainable research excellence with a global perspective on infectious diseases: Centre de Recherches Médicales de Lambaréné (CERMEL), Gabon (2021) (11)
- Malaria antigen-mediated enhancement of interleukin-21 responses of peripheral blood mononuclear cells in African adults. (2008) (11)
- The effect of blood transfusion on outcomes among African children admitted to hospital with Plasmodium falciparum malaria: a prospective, multicentre observational study. (2020) (11)
- Epidemiological, Mycobacteriological, and Clinical Characteristics of Smoking Pulmonary Tuberculosis Patients, in Lambaréné, Gabon: A Cross-Sectional Study. (2020) (11)
- [Malaria therapy in the era of chloroquine resistance]. (1998) (11)
- An alternative dogma on reduced artemisinin susceptibility: A new shadow from east to west (2019) (11)
- Postinfectious irritable bowel syndrome after travelers' diarrhea – a cohort study (2015) (11)
- Limited genetic diversity of the Plasmodium falciparum aquaglyceroporin gene. (2007) (11)
- Novel regulatory SNPs in the promoter region of the TNFRSF18 gene in a Gabonese population. (2011) (11)
- Paediatric Pharmacovigilance: Use of Pharmacovigilance Data Mining Algorithms for Signal Detection in a Safety Dataset of a Paediatric Clinical Study Conducted in Seven African Countries (2014) (11)
- A blinded, controlled trial of an ultrasound device as mosquito repellent. (2000) (10)
- A single-dose antihelminthic treatment does not influence immunogenicity of a meningococcal and a cholera vaccine in Gabonese school children. (2016) (10)
- Clinical diagnosis of malaria: can the patients help us improve? (1996) (10)
- Pyruvate Kinase and Fc&ggr; Receptor Gene Copy Numbers Associated With Malaria Phenotypes (2017) (10)
- Restricted polymorphisms of the mannose-binding lectin gene in a population of Papua New Guinea. (2002) (10)
- High dose chloroquine versus micronized halofantrine in chloroquine-resistant Plasmodium falciparum malaria. (1994) (10)
- Temporal variations in immune responses to conserved regions of Plasmodium falciparum merozoite surface proteins related to the severity of a prior malaria episode in Gabonese children. (2003) (10)
- HDV infection rates in northern Vietnam (2018) (10)
- Molecular surveillance of mutations in the cytochrome b gene of Plasmodium falciparum in Gabon and Ethiopia (2006) (10)
- In vitro activity of new artemisinin derivatives against Plasmodium falciparum clinical isolates from Gabon. (2011) (10)
- Plasmodium falciparum: inhibition of erythrocyte rosette formation and detachment of rosettes by pentoxifylline. (1997) (10)
- Serum Lipids and Lipoproteins During Uncomplicated Malaria: A Cohort Study in Lambaréné, Gabon. (2017) (10)
- CD4+CD25hiFOXP3+ Cells in Cord Blood of Neonates Born from Filaria Infected Mother Are Negatively Associated with CD4+Tbet+ and CD4+RORγt+ T Cells (2014) (10)
- Impact of increasing consultation fees on malaria in Africa (2004) (10)
- HLA DPA1/DPB1 genotype and haplotype frequencies, and linkage disequilibria in Nigeria, Liberia, and Gabon. (1998) (10)
- Experimental infections in humans—historical and ethical reflections (2019) (10)
- Polymorphisms of transporter associated with antigen processing type 1 (TAP1), proteasome subunit beta type 9 (PSMB9) and their common promoter in African children with different manifestations of malaria (2005) (10)
- A case of transient organic brain syndrome during quinine treatment. (1989) (10)
- Point and period prevalences of eczema in rural and urban schoolchildren in Ghana, Gabon and Rwanda (2012) (10)
- Molecular characterization of regulatory polymorphisms in the promoter region of the STAT6 gene in a Gabonese population. (2011) (10)
- AMODIAQUINE-RESISTANT MALARIA IN BRAZIL (1987) (10)
- Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Clusters Based on Integrated Genomic Surveillance, Outbreak Analysis and Contact Tracing in an Urban Setting (2021) (9)
- Correlation of Interleukin-6 levels and lectins during Schistosoma haematobium infection. (2015) (9)
- Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials (2021) (9)
- Sequelae after infection with Trichinella spiralis: a prospective cohort study. (1991) (9)
- Severe malaria in a splenectomised Gabonese woman (2003) (9)
- Longitudinal monitoring of laboratory markers characterizes hospitalized and ambulatory COVID-19 patients (2021) (9)
- Genetic variation in IL-10 is associated with atopic reactivity in Gabonese schoolchildren. (2007) (9)
- Exploratory analysis of the effect of helminth infection on the immunogenicity and efficacy of the asexual blood-stage malaria vaccine candidate GMZ2 (2021) (9)
- Epidemiology of Schistosomiasis and Soil-Transmitted Helminth Coinfections among Schoolchildren Living in Lambaréné, Gabon. (2020) (9)
- DNA recovery from archived RDTs for genetic characterization of Plasmodium falciparum in a routine setting in Lambaréné, Gabon (2019) (9)
- Non-Invasive Antibody Assessment in Saliva to Determine SARS-CoV-2 Exposure in Young Children (2021) (9)
- Antipyretic effect of ibuprofen in Gabonese children with uncomplicated falciparum malaria: a randomized, double-blind, placebo-controlled trial (2008) (9)
- Pyronaridine–artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: A single-arm, open-label, cohort event monitoring study (2021) (9)
- Emergence of B.1.1.318 SARS-CoV-2 viral lineage and high incidence of alpha B.1.1.7 variant of concern in the Republic of Gabon (2021) (9)
- Low frequency of mutations in the X gene, core promoter and precore region of hepatitis B virus infected Vietnamese (2005) (9)
- Comparative genomics revealed adaptive admixture in Cryptosporidium hominis in Africa (2020) (9)
- Prenatal immune responses to Plasmodium falciparum erythrocyte membrane protein 1 DBL-α domain in Gabon (2007) (9)
- Plasmodium falciparum liver-stage antigen-1 peptide-specific interferon-gamma responses are not suppressed during uncomplicated malaria in African children. (2002) (9)
- Automated detection of haemozoin-containing monocytes for the diagnosis of malaria in microscopically negative cases during pregnancy. (2009) (8)
- Birth weight, growth, nutritional status and mortality of infants from Lambaréné and Fougamou in Gabon in their first year of life. (2021) (8)
- Prospective Clinical Trial Assessing Species-Specific Efficacy of Artemether-Lumefantrine for the Treatment of Plasmodium malariae, Plasmodium ovale, and Mixed Plasmodium Malaria in Gabon (2018) (8)
- Short report: evaluation of a simple and inexpensive photometric device for the measurement of hemoglobin. (2004) (8)
- Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination (2020) (8)
- Genetic conservation of the GIL blood group determining aquaporin 3 gene in African and Caucasian populations (2008) (8)
- Resisting and tolerating P. falciparum in pregnancy under different malaria transmission intensities (2017) (8)
- Causes of fever in Gabonese children: a cross-sectional hospital-based study (2020) (8)
- Antimalarial cocktail—tropical flavours of the month (2002) (8)
- Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa (2019) (8)
- Validity and reliability of methods to microscopically detect and quantify malaria parasitaemia (2018) (8)
- Genetic diversity of Plasmodium falciparum infections in one family in Lambaréné. (2000) (8)
- Determinants of post-malarial anemia in African children treated with parenteral artesunate (2019) (8)
- Recognition of Plasmodium falciparum mature gametocyte-infected erythrocytes by antibodies of semi-immune adults and malaria-exposed children from Gabon (2017) (8)
- Association of IP-10 and PDGF-BB levels with clinical forms of chronic Chagas disease. (2013) (8)
- Alterations in the Cytoplasmic Domain of CLCN2 Result in Altered Gating Kinetics (2007) (8)
- Decreasing chloroquine resistance in Plasmodium falciparum isolates from Gabon. (2000) (8)
- A Praziquantel Treatment Study of Immune and Transcriptome Profiles in Schistosoma haematobium-Infected Gabonese Schoolchildren (2019) (8)
- Effect of IL-15 on IgG versus IgE antibody-secreting cells in vitro. (2012) (8)
- Impact of Helminth Infections during Pregnancy on Vaccine Immunogenicity in Gabonese Infants (2020) (8)
- Population structure of Legionella spp. from environmental samples in Gabon, 2013. (2015) (8)
- Age-dependent enhancement of IFN-γ responses to Plasmodium falciparum liver stage antigen-1 T cell epitopes (2002) (8)
- Human complement receptor type 1 (CR1) protein levels and genetic variants in chronic Chagas Disease (2018) (8)
- In vitro growth of Plasmodium falciparum in neonatal blood (2014) (7)
- In Vitro Variant Surface Antigen Expression in Plasmodium falciparum Parasites from a Semi-Immune Individual Is Not Correlated with Var Gene Transcription (2016) (7)
- Splenic interleukin 1 gene expression is associated with accumulation of macrophages and oxygen radical production in Plasmodium vinckei malaria (1994) (7)
- Population Pharmacokinetics of Intravenous Artesunate: A Pooled Analysis of Individual Data From Patients With Severe Malaria. (2014) (7)
- Limited response of NK92 cells to Plasmodium falciparum-infected erythrocytes (2011) (7)
- Simultaneous analysis of interleukin-10 gene microsatellites and single-nucleotide polymorphisms in parallel with tumour necrosis factor and interferon-gamma short tandem repeats by fluorescence-based polymerase chain reaction (2003) (7)
- Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: a WorldWide Antimalarial Resistance Network individual participant data meta-analysis (2019) (7)
- Antibody response in Plasmodium vinckei malaria after treatment with chloroquine and adjuvant interferon-gamma. (1992) (7)
- Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination (2020) (7)
- Polymorphisms in the IFNAR1 gene in patients with chronic hepatitis C: outcome of combined IFN-alpha therapy. (2007) (7)
- Epidemiology of Human Herpes Virus 8 in Pregnant Women and their Newborns--A cross-sectional delivery survey in Central Gabon. (2015) (7)
- Association of low birth weight and polyparasitic infection during pregnancy in Lambaréné, Gabon (2021) (7)
- Pharmacogene Sequencing of a Gabonese Population with Severe Plasmodium falciparum Malaria Reveals Multiple Novel Variants with Putative Relevance for Antimalarial Treatment (2021) (7)
- Soluble MICB protein levels and platelet counts during hepatitis B virus infection and response to hepatocellular carcinoma treatment (2015) (7)
- Performance of a rapid diagnostic test for the detection of Cryptosporidium spp. in African children admitted to hospital with diarrhea (2020) (7)
- Mapping of safe and early chemo-attenuated live Plasmodium falciparum immunization identifies immune signature of vaccine efficacy (2020) (7)
- Soluble tumor necrosis factor receptors in Plasmodium vivax malaria. (1993) (6)
- [Side effects of travel vaccinations. Data collection via telephone survey in Berlin]. (1996) (6)
- Effect of immune regulatory pathways after immunization with GMZ2 malaria vaccine candidate in healthy lifelong malaria-exposed adults. (2020) (6)
- Malaria and onchocerciasis: On HLA and related matters. (1996) (6)
- Geographical distribution of complement receptor type 1 variants and their associated disease risk (2017) (6)
- A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection (2022) (6)
- Effectiveness trials in African children with malaria? (2005) (6)
- [The dual role of tumor necrosis factor (TNF) during a malarial attack]. (1997) (6)
- Emergence and geographic dominance of Omicron subvariants XBB/XBB.1.5 and BF.7 – the public health challenges (2023) (6)
- Controlled human malaria infections using aseptic, purified cryopreserved Plasmodium falciparum sporozoites administered by needle and syringe (2014) (6)
- Variant alleles of the mannose binding lectin 2 gene (MBL2) confer heterozygote advantage within Crohn's families (2010) (6)
- Clindamycin is effective against Plasmodium falciparum but not against P. vivax in mixed infections. (1989) (6)
- Safety and efficacy of the choline analogue SAR97276 for malaria treatment: results of two phase 2, open-label, multicenter trials in African patients (2017) (6)
- Artemether-lumefantrine for the treatment of Plasmodium malariae, Plasmodium ovale, and mixed Plasmodium malaria: A prospective clinical trial assessing species-specific efficacy in Gabon (2018) (6)
- Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine. (2015) (6)
- Human challenge trial workshop: Focus on quality requirements for challenge agents, Langen, Germany, October 22, 2019. (2020) (6)
- Loa loa Infection in Pregnant Women, Gabon (2015) (6)
- How to (ab)use a COVID-19 antigen rapid test with soft drinks? (2021) (6)
- Complementary methods for SARS-CoV-2 diagnosis in times of material shortage (2021) (6)
- Phenotypic characterization of mononuclear blood cells from pregnant Gabonese and their newborns (2011) (6)
- Enhanced laboratory capacity development: a boost for effective tuberculosis control in resource-limited settings. (2017) (6)
- DPA1*0105, a novel DPA1 variant in a negroid population. (1996) (6)
- Viral and serological testing of SARS-CoV-2 among health care workers and patients in Vietnam (2021) (5)
- Erythrocyte glycans as Plasmodium Falciparum rosetting receptors : molecular background of strain specific rosette disruption by glycosaminoglycans and sulfated glycoconjugates (1998) (5)
- DPB1*BR: an Mhc class II DPB1 allele (DPB1*6601) of negroid origin (1996) (5)
- Retrospective clinical case series study in 2017 identifies Plasmodium knowlesi as most frequent Plasmodium species in returning travellers from Thailand to Germany (2018) (5)
- Implementation of multidrug-resistant tuberculosis (MDR-TB) treatment in Gabon: lessons learnt from the field (2019) (5)
- Multiresistant malaria in Brazil cured with low dose clindamycin. (1988) (5)
- Complement 5a Receptor Polymorphisms Are Associated With Panton-Valentine Leukocidin–positive Staphylococcus aureus Colonization in African Pygmies (2018) (5)
- Artemisinin Resistance and the Blame Game. (2016) (5)
- Clonal structure of Staphylococcus aureus colonizing children with sickle cell anaemia and healthy controls (2012) (5)
- Test and treat COVID 65 plus - Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial (2020) (5)
- Reactive nitrogen intermediates and cerebral malaria. (1997) (5)
- Blood volume and red cell mass in children with moderate and severe malaria measured by chromium-53 dilution and gas chromatography/mass spectrometric analysis. (2009) (5)
- Reduced CD3/TCR complex expression leads to immunosuppression during Plasmodium falciparum malaria (2009) (5)
- Workshop report: Malaria vaccine development in Europe--preparing for the future. (2015) (5)
- SAFETY AND IMMUNOGENICITY OF CO-ADMINISTERED HOOKWORM VACCINE CANDIDATES NA-GST-1 AND NA-APR-1 WITH ALHYDROGEL® AND GLUCOPYRANOSYL-LIPID A IN GABONESE ADULTS: INTERIM RESULTS (2017) (5)
- Artemisinin resistance needs to be defined rigorously to be understood: response to Dondorp and Ringwald. (2013) (5)
- Effect of alcohol on growth of Plasmodium falciparum. (2000) (5)
- In vivo anti-malarial effect of the ß-amino alcohol 1t on Plasmodium berghei (2009) (4)
- Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma (2021) (4)
- A long-term follow-up study on otoacoustic emissions testing in paediatric patients with severe malaria in Gabon (2019) (4)
- Interferon-gamma treatment in mice experimentally infected withTrichinella spiralis (2004) (4)
- Non-randomised Ebola trials--lessons for optimal outbreak research. (2016) (4)
- PLASMODIUM FALCIPARUM PARASITE DYNAMICS DETERMINED BY QPCR AFTER CONTROLLED HUMAN MALARIA INFECTION IN SEMI-IMMUNES FROM GABON (2017) (4)
- Upregulation of ICAM-1, IL-1 and reactive oxygen intermediates (ROI) by exogenous antigens from Plasmodium falciparum parasites in vitro, and of sICAM-1 in the acute phase of malaria. (1995) (4)
- Malaria acquired 13 times in two years in Germany. (1997) (4)
- Is large-scale rapid CoV-2 testing a substitute for lockdowns? (2021) (4)
- The Activity of Ozone Against Plasmodium Falciparum (2001) (4)
- Host genetic loci LZTFL1 and CCL2 associated with SARS-CoV-2 infection and severity of COVID-19 (2022) (4)
- Bacterial contamination of water samples in Gabon, 2013. (2017) (4)
- [Progressive malaise and joint pain after travel to Costa Rica]. (2012) (4)
- Plasmodium falciparum 7G8 challenge provides conservative prediction of efficacy of PfNF54-based PfSPZ Vaccine in Africa (2022) (4)
- Extended follow-up of children in a phase2b trial of the GMZ2 malaria vaccine. (2021) (4)
- Clonal evolution and TCR specificity of the human TFH cell response to Plasmodium falciparum CSP (2022) (4)
- Restoration of defective cytokine activity within lepromatous leprosy lesions. (1990) (4)
- Expansion of Functional Myeloid-Derived Suppressor Cells in Controlled Human Malaria Infection (2021) (4)
- Predominance of HBV Genotype B and HDV Genotype 1 in Vietnamese Patients with Chronic Hepatitis (2021) (4)
- Molecular surveillance and genetic divergence of rotavirus A antigenic epitopes in Gabonese children with acute gastroenteritis (2021) (4)
- Medical Informatics in Medical Research (2006) (4)
- Otoacoustic emission testing in Ghanaian children with sickle‐cell disease (2015) (4)
- Minimal effective dose of mefloquine/sulfadoxine/pyrimethamine in mild Plasmodium falciparum malaria. (1995) (3)
- Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinoma (2020) (3)
- Low MBL‐associated serine protease 2 (MASP‐2) levels correlate with urogenital schistosomiasis in Nigerian children (2015) (3)
- Malaria in Central Europe: fears and facts. (2000) (3)
- Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres (2015) (3)
- Concordance of three alternative gestational age assessments for pregnant women from four African countries: A secondary analysis of the MIPPAD trial (2018) (3)
- FOSMIDOMYCIN-PIPERAQUINE AS NON-ARTEMISININ-BASED COMBINATION FOR ACUTE UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA (2017) (3)
- Genetic variants of programmed cell death 1 are associated with HBV infection and liver disease progression (2021) (3)
- Genetic Diversity of Enteric Viruses in Children under Five Years Old in Gabon (2021) (3)
- Epidemiology of dengue fever in Gabon: Results from a health facility-based fever surveillance in Lambaréné and its surroundings. (2021) (3)
- Adolescent Pregnancies in Central Gabon : A Description of Epidemiology and Birth Outcomes (2015) (3)
- Antibody response inPlasmodium vinckei malaria after treatment with chloroquine and adjuvant interferon-γ (2004) (3)
- Cost-effectiveness of intermittent preventive treatment of malaria in infants (IPTi) for averting anaemia in Gabon: a comparison between intention to treat and according to protocol analyses (2011) (3)
- Fosmidomycin as an Antimalarial Agent (2012) (3)
- Short course of quinine plus a single dose of sulfadoxine/pyrimethamine for Plasmodium falciparum malaria (2006) (3)
- OC 8521 PRELIMINARY REPORT ON SAFETY OF CO-ADMINISTERED HUMAN HOOKWORM VACCINE CANDIDATES NA-APR-1 (M74)/ALHYDROGEL® AND NA-GST-1/ALHYDROGEL® IN GABONESE CHILDREN (2019) (2)
- Progressive ulcer on the tongue due to local histoplasmosis (2018) (2)
- More on reactive nitrogen intermediates in human and murine malaria (1995) (2)
- The IgG glycome of SARS-CoV-2 infected individuals reflects disease course and severity (2022) (2)
- Time-to-death is a potential confounder in observational studies of blood transfusion in severe malaria - Authors' reply. (2021) (2)
- Pharmacogenetic considerations in the treatment of co-infections with HIV/AIDS, tuberculosis and malaria in Congolese populations of Central Africa. (2020) (2)
- Prevalence of Pathogens in Young Children Presenting to Hospital with Diarrhea from Lambaréné, Gabon. (2021) (2)
- Plasmodium knowlesi and HIV co-infection in a German traveller to Thailand (2013) (2)
- Influenza A and Parvovirus B19 Seropositivity Rates in Gabonese Infants. (2015) (2)
- Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data (2022) (2)
- Spatiotemporal variation in risk of Shigella infection in childhood: a global risk mapping and prediction model using individual participant data (2022) (2)
- Establishing a controlled hookworm human infection (CHHI) model for Africa: A report from the stakeholders meeting held in Lambaréné, Gabon, November 10–11, 2019 (2021) (2)
- A common polymorphism in the druggable ion channel PIEZO1 is associated with protection from severe malaria (2019) (2)
- Characterization of T cell responses to co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in healthy adults in Gabon (2021) (2)
- Protection of mice previously infected with Plasmodium vinckei against subsequent Salmonella enteritidis infection is associated with nitric oxide production capacity (1997) (2)
- Immunologic Investigations with Oral Live Typhoid Vaccine TY 21A Strain (1989) (2)
- Population Pharmacokinetics of Mefloquine Intermittent Preventive Treatment for Malaria in Pregnancy in Gabon (2018) (2)
- Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity rates (2015) (2)
- Identification of a conserved var gene in different Plasmodium falciparum strains (2020) (2)
- Low incidence of the immune reconstitution inflammatory syndrome among HIV-infected patients starting antiretroviral therapy in Gabon: a prospective cohort study (2017) (2)
- Erratum to: Severe malaria in children leads to a significant impairment of transitory otoacoustic emissions - a prospective multicenter cohort study (2016) (1)
- cacy of Me fl oquine Intermittent Preventive Treatment in Pregnancy Against Schistosoma haematobium Infection in Gabon : A Nested Randomized Controlled Assessor-Blinded Clinical Trial (2013) (1)
- Low Risk of Occult Hepatitis B Infection among Vietnamese Blood Donors (2022) (1)
- Efficacy, T cell activation and antibody responses in accelerated Plasmodium falciparum sporozoite chemoprophylaxis vaccine regimens (2022) (1)
- An efficient single‐cell based method for linking human T cell phenotype to T cell receptor sequence and specificity (2021) (1)
- Malaria in pregnancy in rural Gabon: a cross-sectional survey on the impact of seasonality in high-risk groups (2013) (1)
- Author Correction: Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccination (2020) (1)
- Molecular and functional properties of human Plasmodium falciparum CSP C-terminus antibodies (2023) (1)
- The dual role of tumor necrosis factor (TNF) in malaria (1997) (1)
- The risk to import ESBL-producing Enterobacteriaceae and Staphylococcus aureus through chicken meat trade in Gabon (2014) (1)
- Recognition of Plasmodium falciparum mature gametocyte-infected erythrocytes by antibodies of semi-immune adults and malaria-exposed children from Gabon (2017) (1)
- Urogenital schistosomiasis during pregnancy is associated with low birth weight delivery: Analysis of a prospective cohort of pregnant women in Gabon (2016) (1)
- Creatine kinase-(MB) and hepcidin as candidate biomarkers for early diagnosis of pulmonary tuberculosis: a proof-of-concept study in Lambaréné, Gabon (2022) (1)
- Custom gene expression panel for evaluation of potential molecular markers in hepatocellular carcinoma (2022) (1)
- Diagnosis of pathogens causing bacterial meningitis using Nanopore sequencing in a resource-limited setting (2022) (1)
- Prospective evaluation of artemether-lumefantrine for the treatment of non-falciparum and mixed-species malaria in Gabon (2012) (1)
- Association Between Soluble Notch Ligand Delta-like Ligand 1 and Bleeding Complications in Patients With Dengue Fever Infection (2021) (1)
- Immunological tests to diagnose active tuberculosis (2009) (1)
- Need for optimized dosages in the design of comparative clinical trials of anti-malarial drugs (2022) (1)
- Boromycin has Rapid-Onset Antibiotic Activity Against Asexual and Sexual Blood Stages of Plasmodium falciparum (2022) (1)
- Increased levels of anti-PfCSP antibodies in post-pubertal females versus males immunized with PfSPZ Vaccine does not translate into increased protective efficacy (2022) (1)
- REACTIVE NITROGEN INTERMEDIATES AND CEREBRAL MALARIA. AUTHORS' REPLIES (1997) (1)
- SHORT REPORT Clonal structure of Staphylococcus aureus colonizing children with sickle cell anaemia and healthy controls (2013) (1)
- SOLUBLE HLA-G LEVEL EFFECT ON GMZ2 SPECIFIC IgG PRODUCTION AFTER IMMUNISATION (2017) (1)
- [New ways of treating and preventing malaria: mefloquine (Lariam)]. (1987) (1)
- Immunological profiles associated with distinct parasitemic states in volunteers undergoing malaria challenge in Gabon (2022) (1)
- [Successful treatment of antimony-resistant cutaneous leishmaniasis]. (1987) (1)
- Analysis of tip-tilt compensation for reflective free-space optical satellite communication (2019) (1)
- Oxidative permeabilization? (2002) (1)
- In vitro growth of Plasmodium falciparum in neonatal blood (2014) (1)
- Urinary Metabolic Profiling in Volunteers Undergoing Malaria Challenge in Gabon (2022) (1)
- Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity (2022) (1)
- Non-communicable disease co-morbidity and associated factors in tuberculosis patients: A cross-sectional study in Gabon (2022) (1)
- Evaluation of transient-evoked otoacoustic emissions in a healthy 1 to 10 year pediatric cohort in Sub-Saharan Africa. (2017) (1)
- Temporal distribution of Plasmodium falciparum recrudescence following artemisinin-based combination therapy: an individual participant data meta-analysis (2022) (1)
- [Hypertriglyceridemia related to falciparum malaria: the role played by glycerol]. (2003) (1)
- Criteria for the in-vitro response of Plasmodium falciparum to amodiaquine. (1989) (1)
- Clonal evolution and specificity of the human T follicular helper cell response to Plasmodium falciparum circumsporozoite protein (2021) (1)
- A call to caution when hydroxychloroquine is given to elderly patients with COVID-19 (2021) (1)
- Therapy of uncomplicated falciparum malaria in Europe: MALTHER – a prospective observational multicentre study (2012) (1)
- Extended haematological follow-up after parenteral artesunate in African children with severe malaria (2012) (1)
- 435 Hepatitis B virus genotype mixtures: Clinical relevance and molecular characteristics (2004) (0)
- Faculty Opinions recommendation of Arterolane maleate plus piperaquine phosphate for treatment of uncomplicated Plasmodium falciparum malaria: a comparative, multicenter, randomized clinical trial. (2012) (0)
- [Autoantibodies in lepromatous leprosy]. (1991) (0)
- Soluble Notch ligand DLL1 is associated with bleeding complication in patients with dengue fever infection. (2021) (0)
- A new allelic variation within the 5'-flanking region of the interleukin-10 gene. (2003) (0)
- HDV infection rates in northern Vietnam (2018) (0)
- ' s response to reviews Title : Co-infection of human parvovirus B 19 with Plasmodium falciparum contributes to malaria disease severity in Gabonese patients (2013) (0)
- CLINICAL DIAGNOSIS OF MALARIA. AUTHOR'S REPLY (1996) (0)
- Heterogeneity of severe paediatric malaria in six sites across Africa: A prospective, hospital-based cohort study [MIM-MP-305592] (2005) (0)
- ' s response to reviews Title : Co-infection of human parvovirus B 19 with Plasmodium falciparum contributes to malaria disease severity in Gabonese patients (2013) (0)
- DNA recovery from archived RDTs for genetic characterization of Plasmodium falciparum in a routine setting in Lambaréné, Gabon (2019) (0)
- SARS-CoV-2 B.1.214.1, B.1.214.2 and B.1.620 are predominant lineages between December 2020 and July 2021 in the Republic of Congo (2022) (0)
- Iron metabolism as a basis for antimalarial drug design: inhibitory effects and stimulation of host defense mechanisms by iron chelators (1998) (0)
- ’ s response to reviews Title : Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria-a proposed model-derived age-based regimen for sub-Saharan Africa (2017) (0)
- Identification of lung macrophage secreted biomarkers for the development of rapid, accurate and affordable point-of-care tuberculosis diagnosis test suitable in low income settings (2022) (0)
- Recombination and selection in polymorphic Plasmodium falciparum antigen genes in natural populations (1998) (0)
- DPB1*BR: anMhc class IIDPB1 allele (DPB1*6601) of negroid origin (2007) (0)
- Social dynamics of biomedical research in a sub- Saharan African country. Patterns of participation in clinical research at the Medical Research Unit of the Albert Schweitzer Hospital at Lambaréné, Gabon. (2013) (0)
- Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study (2021) (0)
- Vaccination with fractional doses: promise or illusion? (2022) (0)
- Impact of mannan-binding lectin gene polymorphism in the susceptibility and clinical expression of leprosy (2007) (0)
- Pentoxifylline as adjunct therapy in childen with cerebral malaria [MIM-BL-72864] (2005) (0)
- RE-EVALUATION OF MALARIA DIAGNOSIS BY MOLECULAR METHODS REVEALS MUTATIONS IN HRP-2 AND DRUG RESISTANCE MARKERS IN CAMEROON (2017) (0)
- Effectiveness of antimalarial drug combinations in treating concomitant urogenital schistosomiasis in malaria patients in Lambaréné, Gabon: A non-randomised event-monitoring study (2022) (0)
- P214: Hepatitis E virus super‐infection and progression of liver disease in Vietnamese HBsAg‐positive patients (2015) (0)
- FOXO3A regulatory polymorphism and susceptibility to severe malaria in Gabonese children (2014) (0)
- Cellular and antibody response in GMZ2-vaccinated Gabonese volunteers in a controlled human malaria infection trial (2022) (0)
- Knowledge, attitudes and practices pertaining to urogenital schistosomiasis in Lambaréné and surrounding areas, Gabon (2021) (0)
- Saliva and Plasma Antibody Levels in Children and Adolescents After Primary Infection With Omicron Variants of SARS-CoV-2 Infection in Germany. (2023) (0)
- Low Prevalence of Plasmodium falciparum Histidine-Rich Protein 2 and 3 Gene Deletions—A Multiregional Study in Central and West Africa (2023) (0)
- Comparative multi-OMICS single cell atlas of five COVID-19 (rAdVV and mRNA) vaccines describe unique and distinct mechanisms of action (2022) (0)
- First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2 (2023) (0)
- First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2 (2023) (0)
- Interaction of rheumatoid factor and Entamoeba histolytica. (1989) (0)
- Extending the spectrum of antimalarial treatment : Artemisinin combinations for the treatment of rare Plasmodium species infections and the development of dyes as antimalarials (2017) (0)
- The effect of the benzodiazepine antagonist flumazenil on microfilariae of Monanema martini in vitro. (1990) (0)
- Halofantrine sensitivity (1993) (0)
- Opposed plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria (2008) (0)
- Hydroxychloroquine for treatment of non‐hospitalized adults with COVID‐19: A meta‐analysis of individual participant data of randomized trials (2023) (0)
- Measurement of Matrix Metalloproteinases and Their Tissue Inhibitors in Serum Produces Doubtful Results (2008) (0)
- Co-infection with Schistosoma haematobium modulates the gene expression profile of malaria infection in schoolchildren in Gabon (2014) (0)
- Interferon-Stimulated Gene 15 in HBV Infection and Progression of HBV-Related Liver Diseases (2016) (0)
- Pharmacokinetic Characteristics of Two Paediatric Formulations of Artesunate-Mefloquine in African Children with Acute Uncomplicated Plasmodium falciparum Malaria (2009) (0)
- The exception that proves the rule: Virulence gene expression at the onset of Plasmodium falciparum blood stage infections (2022) (0)
- The effect of immunization schedule with the malaria vaccine candidate RTS,S/AS01E on protective efficacy and anti-circumsporozoite protein antibody avidity in African infants (2015) (0)
- EFFECT OF SCHISTOSOMA HAEMATOBIUM INFECTION ON PLASMODIUM FALCIPARUM MALARIA BURDEN IN LAMBARÉNÉ, GABON (2017) (0)
- Anti-homotypic affinity maturation improves human B cell responses against a repetitive parasite antigen (2018) (0)
- Kangai 1 C-terminal interacting tetraspanin plays an important role in cholangiocarcinogenesis (2017) (0)
- [Chronic recurrent fever as the sole symptom of Yersinia enterocolitica infection]. (1989) (0)
- Diagnosis of pathogens causing bacterial meningitis using Nanopore sequencing in a resource-limited setting (2022) (0)
- Correction: Evidence for in vitro and in vivo activity of the antimalarial pyronaridine against Schistosoma (2022) (0)
- Safety and efficacy of the choline analogue SAR97276 for malaria treatment: results of two phase 2, open-label, multicenter trials in African patients (2017) (0)
- Beta 2-microglobulin and neopterin in semi-immune and non-immune malaria patients. (1990) (0)
- Extended haematological follow-up after parenteral artesunate in African children with severe malaria (2012) (0)
- Glucose-6-phosphate dehydrogenase deficiency and reduced haemoglobin levels in African children with severe malaria (2016) (0)
- Distribution of Knop blood group antigens and association of Triggering receptor expressed on myeloid cells 1 (TREM-1) gene variants in Ghanaian children with malaria (0)
- Low Prevalence of HEV Infection and No Associated Risk of HEV Transmission from Mother to Child among Pregnant Women in Vietnam (2021) (0)
- Repurposing Antimalarials to Tackle the COVID-19 Pandemic (2021) (0)
- Endemic Infectious Diseases in Pregnant Women in Central African Gabon Epidemiology and Evaluation of new Interventions (2015) (0)
- [New preventive antimalaria drug. 3 tables, 2 months of protection. Interview by Petra Eiden]. (2000) (0)
- Combined promoter haplotypes of the IL10R genes are associated with protection against severe malaria in Gabonese children (2011) (0)
- SAFETY OF RVSV EBOLA VACCINE, AFTER 6 MONTHS FOLLOW-UP, IN ADULTS: A PHASE 1 TRIAL CONDUCTED IN LAMBARÉNÉ, GABON (2017) (0)
- Diagnosis of SARS-CoV-2 infections in times of material shortage (2020) (0)
- Structural studies of human antibody responses against leading malaria vaccine antigen PfCSP (2018) (0)
- Nitrate levels in malaria: a reply (1997) (0)
- [Travel diarrhea: attempt at a clinical-epidemiologic evaluation]. (1987) (0)
- Resistance patterns among drug-resistant tuberculosis patients and trends-over-time analysis of national surveillance data in Gabon, Central Africa (2022) (0)
- Development and Validation of an In Silico Decision Tool To Guide Optimization of Intravenous Artesunate Dosing Regimens for Severe Falciparum Malaria Patients (2021) (0)
- A long-term follow-up study on otoacoustic emissions testing in paediatric patients with severe malaria in Gabon (2019) (0)
- Cytokine and chemokine profile of the innate and adaptive immune response of schistosoma haematobium and plasmodium falciparum single and co-infected school-aged children from an endemic area of Lambaréné, Gabon (2015) (0)
- Faculty Opinions recommendation of Doxycycline improves filarial lymphedema independent of active filarial infection: a randomized controlled trial. (2012) (0)
- SAFETY AND EFFICACY OF SAR97276A FOR TREATING MALARIA: TWO OPEN-LABEL MULTICENTER PHASE II CLINICAL STUDIES IN AFRICAN CHILDREN AND ADULTS (2017) (0)
- University of Groningen Population structure of Staphylococcus aureus from remote African (2019) (0)
- An alternative interpretation of the hygiene hypothesis (2001) (0)
- Author's response to reviews Title: Reliable and rapid characterization of functional SNPs in human FCN2 gene reveal diverse geographical patterns. Authors: (2012) (0)
- Reply to Jung (2008) (0)
- Detection and Quantification of Plasmodium DNA in Dried Blood Spots Using a Commercial Real-Time PCR Assay and Filter Card System (2009) (0)
- Species and genotype diversity of Plasmodium in malaria patients from Gabon analysed by next generation sequencing (2017) (0)
- Blood Mononuclear Cells Type 2 Transcripts and Nitric Oxide in Hemozoin-Induced Nitric Oxide Synthase Children with Malarial Anemia : Elevated Nitric Oxide Production in (2004) (0)
- [Infectious diarrhea diseases]. (1989) (0)
- ONE-YEAR SAFETY OF THE RVSV∆G-ZEBOV-GP VACCINE IN ADOLESCENTS AND CHILDREN IN LAMBARENE, GABON (2017) (0)
- RT-PCR-based assessment of the SD Bioline Rota/Adeno Antigen-based test in infants with and without diarrhea (2023) (0)
- Author Correction: Genetic variants of programmed cell death 1 are associated with HBV infection and liver disease progression (2022) (0)
- FP03-MO-01 Endoglin in African children with Plasmodium falciparum malaria: a novel player in severe malaria pathogenesis? (2009) (0)
- The fight against malaria – this month in Vienna (2007) (0)
- Clinical diagnosis of malaria: a reply (1996) (0)
- Tropical Medicine at the University of Tübingen (2010) (0)
- Assessment of malaria transmission intensity and insecticide resistance mechanisms in three rural areas of the Moyen Ogooué Province of Gabon (2022) (0)
- Ring-stage malaria antigens induce high levels of tumor necrosis factor-independent interleukin 6 secretion in blood cells from patients with severe malaria (2010) (0)
- Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countries (2017) (0)
- Cellular and antibody response in GMZ2-vaccinated Gabonese volunteers in a controlled human malaria infection trial (2022) (0)
- Association of CISH -292A/T genetic variant with hepatitis B virus infection (2011) (0)
- Controlled human malaria infections using aseptic, purified cryopreserved Plasmodium falciparum sporozoites administered by needle and syringe (2014) (0)
- A multicenter, prospective study of intraleukocytic and intraerythrocytic pigment as prognostic features in African children with falciparum malaria [MIM-AM-33336] (2005) (0)
- Human complement receptor type 1 (CR1) protein levels and genetic variants in chronic Chagas Disease (2018) (0)
- Mortality, morbidity and developmental outcomes in children born to women receiving either mefloquine or sulphadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancy : a randomized controlled trial (2015) (0)
- T cell accumulation in spleen and liver during murine Plasmodium vinckei malaria (2010) (0)
- Malaria Plasmodium falciparum Induced by Pregnancy-Associated Immune Responses of Cord Blood Cells and IL-10 Mediate Parasite-Specific γ IFN - (2005) (0)
- Life-span of in vitro differentiated Plasmodium falciparum gametocytes (2017) (0)
- Immunity to Malaria : Insights on the Mechanisms Beh ind Effector Functions of Natural Killer Cells (2012) (0)
- Abstracts of the Eighth EDCTP Forum, 6–9 November 2016 (2017) (0)
- Abstracts of the Eighth EDCTP Forum, 6–9 November 2016 (2017) (0)
- Investigation of urinary metabolomics in a phase I hookworm vaccine trial in Gabon (2022) (0)
- Determinants of tuberculosis in Lambaréné and barriers towards successful antituberculous treatment (2016) (0)
- Host and parasite factors influencing clinical malaria in African children (0)
- Knowledge, attitudes and practices pertaining to urogenital schistosomiasis in Lambaréné and surrounding areas, Gabon (2021) (0)
- COMPARATIVE EVALUATION OF GENOTYPE MTBDRPLUS VERSION 2 AND GENE XPERT MTB/RIF ASSAYS TO DETECT MYCOBACTERIUM TUBERCULOSIS AND RESISTANCE GENE PATTERNS IN GABON (2017) (0)
- CONCISE Artesunate and Praziquantel for the Treatment of Schistosoma haematobium Infections: A Double-Blind, Randomized, Placebo-Controlled Study (2001) (0)
- Antimalarial treatment in infants (2022) (0)
- REPORT : IN VITRO ACTIVITY OF ARTEMISONE COMPARED WITH ARTESUNATE AGAINST PLASMODIUM FALCIPARUM (2006) (0)
- P1241 : JAK/STAT pathway and susceptibility to hepatitis B virus infection and related liver diseases (2015) (0)
- Assessment of malaria transmission intensity and insecticide resistance mechanisms in three rural areas of the Moyen Ogooué Province of Gabon (2022) (0)
- Monitoring of efficacy, tolerability and safety of artemether–lumefantrine and artesunate–amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial (2019) (0)
- Efficacy, T cell activation and antibody responses in accelerated Plasmodium falciparum sporozoite chemoprophylaxis vaccine regimens (2022) (0)
- Functional Variants and Aberrant Methylation in the SOCS3 Promoter Region Influence the Progression of HBV-Related Liver Diseases (2016) (0)
- Community-Associated Staphylococcus aureus from Sub-Saharan Africa and Germany: A Cross-Sectional Geographic Correlation Study (2017) (0)
- Kremsner Efficacy , Safety , Tolerability , and Acceptability of Two Paediatric Formulations of Artesunate-Mefloquine in African Children with Acute Uncomplicated Plasmodium falciparum Malaria (2008) (0)
- Ethics of research (2001) (0)
- Alterations of blood coagulation in controlled human malaria infection (2016) (0)
- Faculty of 1000 evaluation for Impact of peginterferon alpha and ribavirin treatment on lipid profiles and insulin resistance in Hepatitis C virus/HIV-coinfected persons: the AIDS Clinical Trials Group A5178 Study. (2012) (0)
- Abstract (1984) (0)
- A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection (2022) (0)
- Persistent Nasal Carriage of Staphylococcus aureus Is Associated with Deficient Induction of Human (cid:1) -Defensin 3 after Sterile Wounding of Healthy Skin In Vivo (cid:1) (2011) (0)
- Reply to Mimica (2012) (0)
- Aetiologies and clinical presentation of central nervous system infections in Vietnamese patients: a prospective study (2022) (0)
- The Association of Blood Transfusion with Outcome among African Children Hospitalized with Plasmodium falciparum Malaria: A Prospective Multicentre Observational Study (2021) (0)
- Genome, proteome, and immunome data explain why 6 month controlled human malaria infection with sporozoites of the Pf7G8 clone of Plasmodium falciparum is a rigorous predictor of the efficacy of the PfNF54-based PfSPZ Vaccine in Africa (2021) (0)
- Pyronaridine-Artesunate combination for the treatment of acute uncomplicated Plasmodium falciparum malaria in paediatric patients in Gabon (2010) (0)
- Principal component analysis (PCA) of cytokine responses to schistosome specific and non-specific antigens. (2015) (0)
- Co-infection with Schistosoma haematobium modulates the gene expression profile of malaria infection in schoolchildren in Gabon (2014) (0)
- Causes of fever in Gabonese children: a cross-sectional hospital-based study (2020) (0)
- Molecular markers of anti-malarial drug resistance in Central, West and East African children with severe malaria (2017) (0)
- Corrigendum to "Epidemiology and population structure of Staphylococcus aureus in various population groups from a rural and semi urban area in Gabon, Central Africa" [Acta Trop. 124 (2012) 42-47]. (2018) (0)
- Need for optimized dosages in the design of comparative clinical trials of anti-malarial drugs (2022) (0)
- The Effect of Ozone on Plasmodium Falciparum-Infected Red Blood Cells (2015) (0)
- [Because current drugs fail more frequently: an former antibiotic as malaria therapy (interview by Waldtraut Paukstadt)]. (2003) (0)
- Malaria falciparum Plasmodium Clearance of Parasitemia in Th 2-Cytokine-Producing T Cells during Reciprocal Regulation of Th 1-and (1998) (0)
- P212: Chronic infection with Hepatitis E virus in pigs co‐infected with the porcine reproductive and respiratory syndrome virus (2015) (0)
- Su.13. NCF1 Gene and Pseudogene Pattern: Association with Parasitic Infection and Autoimmunity (2008) (0)
This paper list is powered by the following services:
Other Resources About Peter Gottfried Kremsner
What Schools Are Affiliated With Peter Gottfried Kremsner?
Peter Gottfried Kremsner is affiliated with the following schools:
